Preview

Rational Pharmacotherapy in Cardiology

Advanced search

РЕКОМЕНДАЦИИ ЕВРОПЕЙСКОГО ОБЩЕСТВА КАРДИОЛОГОВ ПО ДИАГНОСТИКЕ И ЛЕЧЕНИЮ ЗАБОЛЕВАНИЙ ПЕРИФЕРИЧЕСКИХ АРТЕРИЙ

https://doi.org/10.20996/1819-6446-2012-8-4-4-73

Full Text:

Abstract

Члены комитета по практическим рекомендациям: J. Bax (председатель, Нидерланды), A. Auricchio (Швейцария), H. Baumgartner (Германия), C. Ceconi (Италия), V. Dean (Франция), C. Deaton (Великобритания), R. Fagard (Бельгия), C. Funck-Brentano (Франция), D. Hasdai (Израиль), A. Hoes (Нидерланды), J. Knuuti (Финляндия), P . Kolh (Бельгия), T. McDonagh (Великобритания), C. Moulin (Франция), D. Poldermans (Нидерланды), B. Popescu (Румыния), Z. Reiner (Хорватия), U. Sechtem (Германия), P .A. Sirnes (Норвегия), A. Torbicki (Польша), A. Vahanian (Франция), S. Windecker (Швейцария).
Рецензенты: P . Kolh (координатор, Бельгия), A. Torbicki (координатор, Польша), S. Agewall (Норвегия), A. Blinc (Словения), M. Bulvas (Чехия), F . Cosentino (Италия), T. De Backer (Бельгия), A. Gottsäter (Швеция), D. Gulba (Германия), T.J. Guzik (Польша), B. Jönsson (Швеция), G. Késmárky (Венгрия), A. Kitsiou (Греция), W. Kuczmik (Польша), M. L. Larsen (Дания), J. Madaric (Словакия), J-L. Mas†(Франция), J.J.V. Mc-Murray (Великобритания), A. Micari (Италия), M. Mosseri (Израиль), C. Müller (Швейцария), R. Naylor (Великобритания), B. Norrving (Швеция), O. Oto (Турция), T. Pasierski (Польша), P-F . Plouin (Франция), F . Ribichini (Италия), J-B. Ricco (Франция), L. Ruilope (Испания), J.-
P . Schmid (Швейцария), U. Schwehr (Германия), B.G.M. Sol (Нидерланды), M. Sprynger (Бельгия), C. Tiefenbacher (Германия), C. Tsioufis (Греция), H. Van Damme (Бельгия).

About the Authors

M. Tendera
3rd Division of Cardiology, Medical University of Silesia
Poland


V. Aboyans
Dupuytren University Hospital
France


M-L. Bartelink

Netherlands


I. Baumgartner

Switzerland


D. Clément

Belgium


J-P. Collet

France


A. Cremonesi

Italy


M. De Carlo

Italy


J. Ostergren

Sweden


D. Poldermans

Netherlands


V. Riambau

Spain


M. Roffi

Switzerland


J. Röther

Germany


H. Sievert

Germany


M. van Sambeek

Netherlands


T. Zeller

Germany


R. Erbel

Germany


F. G. R. Fowkes

United Kingdom


M. Heras

Spain


S. Kownator

France


E. Minar

Austria


References

1. Steg PG, Bhatt DL, Wilson PW, D’Agostino R Sr, Ohman EM, Rother J, Liau CS, Hirsch AT, Mas JL, Ikeda Y, Pencina MJ, Goto S. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 2007;297: 1197–1206.

2. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, Browner D. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992;326:381–386.

3. Sigvant B, Wiberg-Hedman K, Bergqvist D, Rolandsson O, Andersson B, Persson E, Wahlberg E. A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences. J Vasc Surg 2007;45:1185–1191.

4. Kroger K, Stang A, Kondratieva J, Moebus S, Beck E, Schmermund A, Mohlenkamp S, Dragano N, Siegrist J, Jockel KH, Erbel R. Prevalence of peripheral arterial disease—results of the Heinz Nixdorf recall study. Eur J Epidemiol 2006;21:279–285.

5. Kannel WB, McGee DL. Update on some epidemiologic features of intermittent claudication: the Framingham Study. J Am Geriatr Soc 1985;33:13–18.

6. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007;45:S5–S67.

7. Ingolfsson IO, Sigurdsson G, Sigvaldason H, Thorgeirsson G, Sigfusson N. A marked decline in the prevalence and incidence of intermittent claudication in Icelandic men 1968–1986: a strong relationship to smoking and serum cholesterol—the Reykjavik Study. J Clin Epidemiol 1994;47:1237–1243.

8. Murabito JM, Evans JC, D’Agostino RB Sr, Wilson PW, Kannel WB. Temporal trends in the incidence of intermittent claudication from 1950 to 1999. Am J Epidemiol 2005;162:430–437.

9. Bots ML, Breslau PJ, Briet E, de Bruyn AM, van Vliet HH, van den Ouweland FA, de Jong PT, Hofman A, Grobbee DE. Cardiovascular determinants of carotid artery disease. The Rotterdam Elderly Study. Hypertension 1992;19:717–720.

10. Mathiesen EB, Joakimsen O, Bonaa KH. Prevalence of and risk factors associated with carotid artery stenosis: the Tromso Study. Cerebrovasc Dis 2001;12:44–51.

11. O’Leary DH, Polak JF, Kronmal RA, Kittner SJ, Bond MG, Wolfson SK Jr, BommerW, Price TR, Gardin JM, Savage PJ. Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. The CHS Collaborative Research Group. Stroke 1992;23:1752–1760.

12. Hansen KJ, Edwards MS, Craven TE, Cherr GS, Jackson SA, Appel RG, Burke GL, Dean RH. Prevalence of reno-vascular disease in the elderly: a population-based study. J Vasc Surg 2002;36:443–451.

13. de Mast Q, Beutler JJ. The prevalence of atherosclerotic renal artery stenosis in risk groups: a systematic literature review. J Hypertens 2009;27:1333–1340.

14. Valentine RJ, Martin JD, Myers SI, Rossi MB, Clagett GP. Asymptomatic celiac and superior mesenteric artery stenoses are more prevalent among patients with unsuspected renal artery stenoses. J Vasc Surg 1991;14:195–199.

15. Shadman R, Criqui MH, Bundens WP, Fronek A, Denenberg JO, Gamst AC, McDermott MM. Subclavian artery stenosis: prevalence, risk factors, and association with cardiovascular diseases. J Am Coll Cardiol 2004;44:618–623.

16. Fowkes FG, Housley E, Riemersma RA, Macintyre CC, Cawood EH, Prescott RJ, Ruckley CV. Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study. Am J Epidemiol 1992;135:331–340.

17. Criqui MH. Peripheral arterial disease—epidemiological aspects. Vasc Med 2001;6:3–7.

18. Stoffers HE, Rinkens PE, Kester AD, Kaiser V, Knottnerus JA. The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease. Int J Epidemiol 1996;25:282–290.

19. Meijer WT, Hoes AW, Rutgers D, Bots ML, Hofman A, Grobbee DE. Peripheral arterial disease in the elderly: the Rotterdam Study. Arterioscler Thromb Vasc Biol 1998;18:185–192.

20. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 2001;285:2481–2485.

21. Chrysochou C, Kalra PA. Epidemiology and natural history of atherosclerotic renovascular disease. Prog Cardiovasc Dis 2009;52:184–195.

22. English JA, Carell ES, Guidera SA, Tripp HF. Angiographic prevalence and clinical predictors of left subclavian stenosis in patients undergoing diagnostic cardiac catheterization. Catheter Cardiovasc Interv 2001;54:8–11.

23. Pickett CA, Jackson JL, Hemann BA, Atwood JE. Carotid bruits as a prognostic indicator of cardiovascular death and myocardial infarction: a meta-analysis. Lancet 2008;371:1587–1594.

24. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Rui-lope L, Sans-Menendez S, Scholte op Reimer W, Weissberg P, Wood D, Yarnell J, Zamorano JL,Walma E, Fitzgerald T, Cooney MT, Dudina A. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur Heart J 2007;28:2375–2414.

25. Reiner Z, Catapano A, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Perrone Filardi P, Riccardi G, Storey RF, Wood D. ESC/EAS Guidelines for the managemeint of dyslipidaemias. Eur Heart J 2011;32:1769–1818.

26. Fowkes FG, Price JF, Stewart MC, Butcher I, Leng GC, Pell AC, Sandercock PA, Fox KA, Lowe GD, Murray GD. Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial. JAMA 2010;303:841–848.

27. Criqui MH, McClelland RL, McDermott MM, Allison MA, Blumenthal RS, Aboyans V, Ix JH, Burke GL, Liu K, Shea

28. S. The ankle–brachial index and incident cardiovascular events in the MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2010;56:1506–1512.

29. Ruehm SG, Goyen M, Barkhausen J, Kroger K, Bosk S, Ladd ME, Debatin JF. Rapid magnetic resonance angiography for detection of atherosclerosis. Lancet 2001;357:1086–1091.

30. Goyen M, Quick HH, Debatin JF, Ladd ME, Barkhausen J, Herborn CU, Bosk S, Kuehl H, Schleputz M, Ruehm SG. Whole-body three-dimensional MR angiography with a rolling table platform: initial clinical experience. Radiology 2002;224:270–277.

31. Gohde SC, Goyen M, Forsting M, Debatin JF. [Prevention without radiation—a strategy for comprehensive early detection using magnetic resonance tomography]. Radiologe 2002;42:622–629.

32. Fenchel M, Scheule AM, Stauder NI, Kramer U, Tomaschko K, Nagele T, Bretschneider C, Schlemmer HP, Claussen CD, Miller S. Atherosclerotic disease: whole-body cardiovascular imaging with MR system with 32 receiver channels and total-body surface coil technology—initial clinical results. Radiology 2006;238:280–291.

33. Fowler B, Jamrozik K, Norman P, Allen Y. Prevalence of peripheral arterial disease: persistence of excess risk in former smokers. Aust N Z J Public Health 2002;26:219–224.

34. Smith FB, Lowe GD, Lee AJ, Rumley A, Leng GC, Fowkes FG. Smoking, hemorheologic factors, and progression of peripheral arterial disease in patients with claudication. J Vasc Surg 1998;28:129–135.

35. Steinberg MB, Greenhaus S, Schmelzer AC, Bover MT, Foulds J, Hoover DR, Carson JL. Triple-combination pharmacotherapy for medically ill smokers: a randomized trial. Ann Intern Med 2009;150:447–454.

36. Aboyans V, Thomas D, Lacroix P. The cardiologist and smoking cessation. Curr Opin Cardiol 2010;25:469–477.

37. Collins R, Armitage J, Parish S, Sleigh P, Peto R. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 2003;361:2005–2016.

38. Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, Meade T, Patrono C, Roncaglioni MC, Zanchetti A. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009;373:1849–1860.

39. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CA-PRIE Steering Committee. Lancet 1996;348:1329–1339.

40. Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, Flather MD, Haffner SM, Hamm CW, Hankey GJ, Johnston SC, Mak KH, Mas JL, Montalescot G, Pearson TA, Steg PG, Steinhubl SR, Weber MA, Brennan DM, Fabry-Ribaudo L, Booth J, Topol EJ; CHARISMA Investigators. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006;354:1706–1717.

41. Cacoub PP, Bhatt DL, Steg PG, Topol EJ, Creager MA. Patients with peripheral arterial disease in the CHARISMA trial. Eur Heart J 2009;30:192–201.

42. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, Mc-Gregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E, Am-brosioni E, Lindholm LH, Manolis A, Nilsson PM, Redon J, Struijker-Boudier HA, Viigimaa M, Adamopoulos S, Bertomeu V, Clement D, Farsang C, Gaita D, Lip G, Mallion JM, Manolis AJ, O’Brien E, Ponikowski P, Ruschitzka F, Tamargo J, van Zwieten P, Waeber B, Williams B, The task force for the management of arterial hypertension of the European Society of Hypertension, The task force for the management of arterial hypertension of the European Society of Cardiology. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007;28:1462–1536.

43. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clement D, Coca A, Do-miniczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heagerty A, Kjeldsen SE, Kiowski W, Mallion JM, Manolis A, Narkiewicz K, Nilsson P, Olsen MH, Rahn KH, Redon J, Rodicio J, Ruilope L, Schmieder RE, Struijker-Boudier HA, van Zwieten PA, Viigimaa M, Zanchetti A; European Society of Hypertension. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009;27:2121–2158.

44. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145–153.

45. Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008;358:1547–1559.

46. Radack K, Deck C. Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials. Arch Intern Med 1991;151:1769–1776.

47. Aronow WS, Ahn C. Effect of beta blockers on incidence of new coronary events in older persons with prior myocardial infarction and symptomatic peripheral arterial disease. Am J Cardiol 2001;87:1284–1286.

48. Poldermans D, Bax JJ, Boersma E, De Hert S, Eeckhout E, Fowkes G, Gorenek B, Hennerici MG, Lung B, Kelm M, Kjeldsen KP, Kristensen SD, Lopez-Sendon J, Pelosi P, Philippe F, Pierard L, Ponikowski P, Schmid JP, Sellevold OF, Sicari R, Van den Berghe G, Vermassen F, Hoeks SE, Vanhorebeek I. Guidelines for preoperative cardiac risk assessment and perioperative cardiac management in noncardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and European Society of Anaesthesiology (ESA). Eur Heart J 2009;30:2769–2812.

49. Hobbs SD, Bradbury AW. Smoking cessation strategies in patients with peripheral arterial disease: an evidence-based approach. Eur J Vasc Endovasc Surg 2003;26:341–347.

50. Grau AJ, Weimar C, Buggle F, Heinrich A, Goertler M, Neumaier S, Glahn J, Brandt T, Hacke W, Diener HC. Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke 2001;32: 2559–2566.

51. Barnett HJ, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, Rankin RN, Clagett GP, Hachinski VC, Sack-ett DL, Thorpe KE, Meldrum HE. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1998;339:1415–1425.

52. European Carotid Surgery Trialists’ Collaborative Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998;351:1379–1387.

53. Inzitari D, Eliasziw M, Gates P, Sharpe BL, Chan RK, Meldrum HE, Barnett HJ. The causes and risk of stroke in patients with asymptomatic internal-carotid-artery stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 2000;342:1693–1700.

54. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA 1995;273:1421–1428.

55. Halliday A, Mansfield A, Marro J, Peto C, Peto R, Potter J, Thomas D. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 2004;363:1491–1502.

56. Abbott AL. Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis. Stroke 2009;40:e573–e583.

57. Schneider PA, Naylor AR. Transatlantic debate. Asymptomatic carotid artery stenosis—medical therapy alone versus medical therapy plus carotid endarterectomy or stenting. Eur J Vasc Endovasc Surg 2010;40:274–281.

58. Rothwell PM, Giles MF, Flossmann E, Lovelock CE, Redgrave JN, Warlow CP, Mehta Z. A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack. Lancet 2005;366:29–36.

59. Grant EG, Benson CB, Moneta GL, Alexandrov AV, Baker JD, Bluth EI, Carroll BA, Eliasziw M, Gocke J, Hertzberg BS, Katanick S, Needleman L, Pellerito J, Polak JF, Rholl KS, Wooster DL, Zierler RE. Carotid artery stenosis: gray-scale and Doppler US diagnosis—Society of Radiologists in Ultrasound Consensus Conference. Radiology 2003;229:340–346.

60. Wardlaw JM, Chappell FM, Stevenson M, De Nigris E, Thomas S, Gillard J, Berry E, Young G, Rothwell P, Roditi G, Gough M, Brennan A, Bamford J, Best J. Accurate, practical and cost-effective assessment of carotid steno-sis in the UK. Health Technol Assess 2006;10:iii–iv, ix–x, 1–182.

61. Amarenco P, Bogousslavsky J, Callahan A 3rd, Goldstein LB, Hennerici M, Rudolph AE, Sillesen H, Simunovic L, Szarek M, Welch KM, Zivin JA. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006;355:549–559.

62. Sillesen H, Amarenco P, Hennerici MG, Callahan A, Goldstein LB, Zivin J, Messig M, Welch KM. Atorvastatin re duces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke 2008;39:3297–3302.

63. Bond R, Rerkasem K, AbuRahma AF, Naylor AR, Rothwell PM. Patch angioplasty versus primary closure for carotid endarterectomy. Cochrane Database Syst Rev 2004;2:CD000160.

64. Mannheim D, Weller B, Vahadim E, Karmeli R. Carotid endarterectomy with a polyurethane patch versus primary closure: a prospective randomized study. J Vasc Surg 2005;41:403–407; discussion 407–408.

65. Cao PG, de Rango P, Zannetti S, Giordano G, Ricci S, Celani MG. Eversion versus conventional carotid endarterectomy for preventing stroke. Cochrane Database Syst Rev 2001;1:CD001921.

66. Lewis SC, Warlow CP, Bodenham AR, Colam B, Rothwell PM, Torgerson D, Dellagrammaticas D, Horrocks M, Liapis C, Banning AP, Gough M, Gough MJ. General anaesthesia versus local anaesthesia for carotid surgery (GALA): a multicentre, randomised controlled trial. Lancet 2008;372:2132–2142.

67. Halliday A, Harrison M, Hayter E, Kong X, Mansfield A, Marro J, Pan H, Peto R, Potter J, Rahimi K, Rau A, Robert-son S, Streifler J, Thomas D. 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. Lancet 2010;376:1074–1084.

68. McKevitt FM, Randall MS, Cleveland TJ, Gaines PA, Tan KT, Venables GS. The benefits of combined anti-platelet treatment in carotid artery stenting. Eur J Vasc Endovasc Surg 2005;29:522–527.

69. Dalainas I, Nano G, Bianchi P, Stegher S, Malacrida G, Tealdi DG. Dual antiplatelet regime versus acetyl-acetic acid for carotid artery stenting. Cardiovasc Intervent Radiol 2006;29:519–521.

70. Roffi M, Sievert H, GrayWA, White CJ, Torsello G, Cao P, Reimers B, Mathias K, Setacci C, Schonholz C, Clair DG, Schillinger M, Grunwald I, Bosiers M, Abou-Chebl A, Moussa ID, Mudra H, Iyer SS, Scheinert D, Yadav JS, van Sambeek MR, Holmes DR, Cremonesi A. Carotid artery stenting versus surgery: adequate comparisons? Lancet Neurol 2010;9:339–341.

71. Barbato JE, Dillavou E, Horowitz MB, Jovin TG, Kanal E, David S, Makaroun MS. A randomized trial of carotid artery stenting with and without cerebral protection. J Vasc Surg 2008;47:760–765.

72. Macdonald S, Evans DH, Griffiths PD, McKevitt FM, Venables GS, Cleveland TJ, Gaines PA. Filter-protected versus unprotected carotid artery stenting: a randomised trial. Cerebrovasc Dis 2010;29:282–289.

73. Kastrup A, Nagele T, Groschel K, Schmidt F, Vogler E, Schulz J, Ernemann U. Incidence of new brain lesions after carotid stenting with and without cerebral protection. Stroke 2006;37:2312–2316.

74. Garg N, Karagiorgos N, Pisimisis GT, Sohal DP, Longo GM, Johanning JM, Lynch TG, Pipinos II. Cerebral protection devices reduce periprocedural strokes during carotid angioplasty and stenting: a systematic review of the current literature. J Endovasc Ther 2009;16:412–427.

75. Zahn R, Mark B, Niedermaier N, Zeymer U, Limbourg P, Ischinger T, Haerten K, Hauptmann KE, Leitner ER, Kasper W, Tebbe U, Senges J. Embolic protection devices for carotid artery stenting: better results than stenting without protection? Eur Heart J 2004;25:1550–1558.

76. Cremonesi A, Manetti R, Setacci F, Setacci C, Castriota F. Protected carotid stenting: clinical advantages and complications of embolic protection devices in 442 consecutive patients. Stroke 2003;34:1936–1941.

77. Jansen O, Fiehler J, Hartmann M, Bruckmann H. Protection or nonprotection in carotid stent angioplasty: the influence of interventional techniques on outcome data from the SPACE Trial. Stroke 2009;40:841–846.

78. Bonati LH, Jongen LM, Haller S, Flach HZ, Dobson J, Nederkoorn PJ, Macdonald S, Gaines PA, Waaijer A, Stierli P, Jager HR, Lyrer PA, Kappelle LJ, Wetzel SG, van der Lugt A, Mali WP, Brown MM, van der Worp HB, Engelter ST. New ischaemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: a sub-study of the International Carotid Stenting Study (ICSS). Lancet Neurol 2010;9:353–362.

79. Massop D, Dave R, Metzger C, Bachinsky W, Solis M, Shah R, Schultz G, Schreiber T, Ashchi M, Hibbard R. Stenting and angioplasty with protection in patients at high-risk for endarterectomy: SAPPHIRE Worldwide Registry first 2,001 patients. Catheter Cardiovasc Interv 2009;73:129–136.

80. Brott TG, Hobson RW 2nd, Howard G, Roubin GS, Clark WM, Brooks W, Mackey A, Hill MD, Leimgruber PP, Sheffet AJ, Howard VJ, Moore WS, Voeks JH, Hopkins LN, Cutlip DE, Cohen DJ, Popma JJ, Ferguson RD, Cohen SN, Blackshear JL, Silver FL, Mohr JP, Lal BK, Meschia JF. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med 2010;363:11–23.

81. Stabile E, Salemme L, Sorropago G, Tesorio T, Nammas W, Miranda M, Popusoi G, Cioppa A, Ambrosini V, Cota L, Petroni G, Della Pietra G, Ausania A, Fontanelli A, Biamino G, Rubino P. Proximal endovascular occlusion for carotid artery stenting: results from a prospective registry of 1,300 patients. J Am Coll Cardiol 2010;55:1661–1667.

82. Hobson RW 2nd, Weiss DG, Fields WS, Goldstone J, Moore WS, Towne JB, Wright CB. Efficacy of carotid en-darterectomy for asymptomatic carotid stenosis. The Veterans Affairs Cooperative Study Group. N Engl J Med 1993;328:221–227.

83. Roffi M, Mukherjee D, Clair DG. Carotid artery stenting vs. endarterectomy. Eur Heart J 2009;30:2693–2704.

84. Gray WA, Yadav JS, Verta P, Scicli A, Fairman R, Wholey M, Hopkins LN, Atkinson R, Raabe R, Barnwell S, Green

85. R. The CAPTURE registry: results of carotid stenting with embolic protection in the post approval setting. Catheter Cardiovasc Interv 2007;69:341–348.

86. Katzen BT, Criado FJ, Ramee SR, Massop DW, Hopkins LN, Donohoe D, Cohen SA, Mauri L. Carotid artery stenting with emboli protection surveillance study: thirty-day results of the CASES-PMS study. Catheter Cardiovasc Interv 2007; 70:316–323.

87. Theiss W, Hermanek P, Mathias K, Ahmadi R, Heuser L, Hoffmann FJ, Kerner R, Leisch F, Sievert H, von Sommoggy S. Pro-CAS: a prospective registry of carotid angioplasty and stenting. Stroke 2004;35:2134–2139.

88. Sidawy AN, Zwolak RM, White RA, Siami FS, Schermerhorn ML, Sicard GA. Risk-adjusted 30-day outcomes of carotid stenting and endarterectomy: results from the SVS Vascular Registry. J Vasc Surg 2009;49:71–79.

89. GrayWA, Chaturvedi S, Verta P. Thirty-day outcomes for carotid artery stenting in 6320 patients from 2 prospective, multicenter, high-surgical-risk registries. Circ Cardiovasc Interv 2009;2:159–166.

90. Rothwell PM, Giles MF, Chandratheva A, Marquardt L, Geraghty O, Redgrave JN, Lovelock CE, Binney LE, Bull LM, Cuthbertson FC, Welch SJ, Bosch S, Alexander FC, Silver LE, Gutnikov SA, Mehta Z; Early use of Existing Preventive Strategies for Stroke (EXPRESS) study. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet 2007;370:1432–1442.

91. Luengo-Fernandez R, Gray AM, Rothwell PM. Effect of urgent treatment for transient ischaemic attack and minor stroke on disability and hospital costs (EXPRESS study): a prospective population-based sequential comparison. Lancet Neurol 2009;8:235–243.

92. Naylor AR. The importance of initiating ‘best medical therapy’ and intervening as soon as possible in patients with symptomatic carotid artery disease: time for a radical rethink of practice. J Cardiovasc Surg (Torino) 2009;50:773–782.

93. Mayberg MR, Wilson SE, Yatsu F, Weiss DG, Messina L, Hershey LA, Colling C, Eskridge J, Deykin D, Winn HR. Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis. Veterans Affairs Cooperative Studies Program 309 Trialist Group. JAMA 1991;266:3289–3294.

94. Rothwell PM, Eliasziw M, Gutnikov SA, Fox AJ, Taylor DW, Mayberg MR, Warlow CP, Barnett HJ. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 2003;361:107–116.

95. Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJ. Endarterectomy for symptomatic carotid steno-sis in relation to clinical subgroups and timing of surgery. Lancet 2004;363:915–924.

96. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Trans-luminal Angioplasty Study (CAVATAS): a randomised trial. Lancet 2001;357:1729–1737.

97. Mas JL, Chatellier G, Beyssen B, Branchereau A, Moulin T, Becquemin JP, Larrue V, Lievre M, Leys D, Bonneville JF, Watelet J, Pruvo JP, Albucher JF, Viguier A, Piquet P, Garnier P, Viader F, Touze E, Giroud M, Hosseini H, Pillet JC, Favrole P, Neau JP, Ducrocq X. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 2006;355:1660–1671.

98. Ederle J, Dobson J, Featherstone RL, Bonati LH, van der Worp HB, de Borst GJ, Lo TH, Gaines P, Dorman PJ, Macdonald S, Lyrer PA, Hendriks JM, McCollum C, Nederkoorn PJ, Brown MM. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial. Lancet 2010;375:985–997.

99. Fiehler J, Jansen O, Berger J, Eckstein HH, Ringleb PA, Stingele R. Differences in complication rates among the centres in the SPACE study. Neuroradiology 2008; 50:1049–1053.

100. Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ, Bajwa TK, Whitlow P, Strickman NE, Jaff MR, Popma JJ, Snead DB, Cutlip DE, Firth BG, Ouriel K. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004;351:1493–1501.

101. Gurm HS, Yadav JS, Fayad P, Katzen BT, Mishkel GJ, Bajwa TK, Ansel G, Strickman NE, Wang H, Cohen SA, Massaro JM, Cutlip DE. Long-term results of carotid stenting versus endarterectomy in high-risk patients. N Engl J Med 2008;358:1572–1579.

102. Ederle J, Bonati LH, Dobson J, Featherstone RL, Gaines PA, Beard JD, Venables GS, Markus HS, Clifton A, Sandercock P, Brown MM. Endovascular treatment with angioplasty or stenting versus endarterectomy in patients with carotid artery stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CA-VATAS): long-term follow-up of a randomised trial. Lancet Neurol 2009;8:898–907.

103. Ringleb PA, Allenberg J, Bruckmann H, Eckstein HH, Fraedrich G, Hartmann M, Hennerici M, Jansen O, Klein G, Kunze A, Marx P, Niederkorn K, Schmiedt W, Solymosi L, Stingele R, Zeumer H, HackeW. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet 2006;368:1239–1247.

104. Eckstein HH, Ringleb P, Allenberg JR, Berger J, Fraedrich G, Hacke W, Hennerici M, Stingele R, Fiehler J, Zeumer H, Jansen O. Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trial. Lancet Neurol 2008;7:893–902.

105. Mas JL, Chatellier G, Beyssen B. Carotid angioplasty and stenting with and without cerebral protection: clinical alert from the Endarterectomy Versus Angioplasty in Patients With Symptomatic Severe Carotid Stenosis (EVA-3S) trial. Stroke 2004;35:e18–e20.

106. Mas JL, Trinquart L, Leys D, Albucher JF, Rousseau H, Viguier A, Bossavy JP, Denis B, Piquet P, Garnier P, Viader F, Touze E, Julia P, Giroud M, Krause D, Hosseini H, Becquemin JP, Hinzelin G, Houdart E, Henon H, Neau JP, Bracard S, Onnient Y, Padovani R, Chatellier G. Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial: results up to 4 years from a randomised, multicentre trial. Lancet Neurol 2008;7:885–892.

107. Economopoulos KP, Sergentanis TN, Tsivgoulis G, Mariolis AD, Stefanadis C. Carotid artery stenting versus carotid endarterectomy: a comprehensive meta-analysis of short-term and long-term outcomes. Stroke 2011;42:687–692.

108. Marquardt L, Kuker W, Chandratheva A, Geraghty O, Rothwell PM. Incidence and prognosis of ≥50% symptomatic vertebral or basilar artery stenosis: prospective population-based study. Brain 2009;132:982–988.

109. Bogousslavsky J, Van Melle G, Regli F. The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke. Stroke 1988;19:1083–1092.

110. Bogousslavsky J, Regli F. Borderzone infarctions distal to internal carotid artery occlusion: prognostic implications. Ann Neurol 1986;20:346–350.

111. Wityk RJ, Chang HM, Rosengart A, Han WC, DeWitt LD, Pessin MS, Caplan LR. Proximal extracranial vertebral artery disease in the New England Medical Center Posterior Circulation Registry. Arch Neurol 1998;55:470–478.

112. Caplan LR, Wityk RJ, Glass TA, Tapia J, Pazdera L, Chang HM, Teal P, Dashe JF, Chaves CJ, Breen JC, Vemmos K, Amarenco P, Tettenborn B, Leary M, Estol C, Dewitt LD, Pessin MS. New England Medical Center Posterior Circulation registry. Ann Neurol 2004;56:389–398.

113. Khan S, Cloud GC, Kerry S, Markus HS. Imaging of vertebral artery stenosis: a systematic review. J Neurol Neurosurg Psychiatry 2007;78:1218–1225.

114. Berguer R, Flynn LM, Kline RA, Caplan L. Surgical reconstruction of the extracranial vertebral artery: management and outcome. J Vasc Surg 2000;31:9–18.

115. Aboyans V, Criqui MH, McDermott MM, Allison MA, Denenberg JO, Shadman R, Fronek A. The vital prognosis of subclavian stenosis. J Am Coll Cardiol 2007;49:1540–1545.

116. Sixt S, Rastan A, Schwarzwalder U, Burgelin K, Noory E, Schwarz T, Beschorner U, Frank U, Muller C, Hauk M, Leppanen O, Hauswald K, Brantner R, Nazary T, Neumann FJ, Zeller T. Results after balloon angioplasty or stenting of atherosclerotic subclavian artery obstruction. Catheter Cardiovasc Interv 2009;73:395–403.

117. De Vries JP, Jager LC, Van den Berg JC, Overtoom TT, Ackerstaff RG, Van de Pavoordt ED, Moll FL. Durability of percutaneous transluminal angioplasty for obstructive lesions of proximal subclavian artery: long-term results. J Vasc Surg 2005;41:19–23.

118. Cina CS, Safar HA, Lagana A, Arena G, Clase CM. Subclavian carotid transposition and bypass grafting: consecutive cohort study and systematic review. J Vasc Surg 2002;35:422–429.

119. Hughes K, Hamdan A, Schermerhorn M, Giordano A, Scovell S, Pomposelli F Jr. Bypass for chronic ischemia of the upper extremity: results in 20 patients. J Vasc Surg 2007;46:303–307.

120. Bakken AM, Palchik E, Saad WE, Hart JP, Singh MJ, Rhodes JM, Waldman DL, Davies MG. Outcomes of en-doluminal therapy for ostial disease of the major branches of the aortic arch. Ann Vasc Surg 2008;22:388–394.

121. Lee AD, Agarwal S, Sadhu D. A 7-year experience with thoracoscopic sympathectomy for critical upper limb ischemia. World J Surg 2006;30:1644–1647.

122. Thomas JH, Blake K, Pierce GE, Hermreck AS, Seigel E. The clinical course of asymptomatic mesenteric arterial stenosis. J Vasc Surg 1998;27:840–844.

123. van Bockel JH, Geelkerken RH, Wasser MN. Chronic splanchnic ischaemia. Best Pract Res Clin Gastroenterol 2001;15:99–119.

124. Babu SC, Shah PM. Celiac territory ischemic syndrome in visceral artery occlusion. Am J Surg 1993;166:227–230.

125. Liberski SM, Koch KL, Atnip RG, Stern RM. Ischemic gastroparesis: resolution after revascularization. Gastroenterology 1990;99:252–257.

126. Taylor LM Jr, Moneta GL. Intestinal ischemia. Ann Vasc Surg 1991;5:403–406.

127. Ghosh S, Roberts N, Firmin RK, Jameson J, Spyt TJ. Risk factors for intestinal ischaemia in cardiac surgical patients. Eur J Cardiothorac Surg 2002;21:411–416.

128. Wilson DB, Mostafavi K, Craven TE, Ayerdi J, Edwards MS, Hansen KJ. Clinical course of mesenteric artery stenosis in elderly Americans. Arch Intern Med 2006;166:2095–2100.

129. Mensink PB, van Petersen AS, Geelkerken RH, Otte JA, Huisman AB, Kolkman JJ. Clinical significance of splanchnic artery stenosis. Br J Surg 2006;93:1377–1382.

130. Moawad J, Gewertz BL. Chronic mesenteric ischemia. Clinical presentation and diagnosis. Surg Clin NorthAm 1997;77:357–369.

131. Pellerito JS, Revzin MV, Tsang JC, Greben CR, Naidich JB. Doppler sonographic criteria for the diagnosis of inferior mesenteric artery stenosis. J Ultrasound Med 2009;28:641–650.

132. Moneta GL, Lee RW, Yeager RA, Taylor LM Jr, Porter JM. Mesenteric duplex scanning: a blinded prospective study. J Vasc Surg 1993;17:79–84; discussion 85–76.

133. Armstrong PA. Visceral duplex scanning: evaluation before and after artery intervention for chronic mesenteric

134. ischemia. Perspect Vasc Surg Endovasc Ther 2007;19:386–392; discussion 393–384.

135. Dietrich CF, Jedrzejczyk M, Ignee A. Sonographic assessment of splanchnic arteries and the bowel wall. Eur JRadiol 2007;64:202–212.

136. Zwolak RM. Can duplex ultrasound replace arteriography in screening for mesenteric ischemia? Semin VascSurg 1999;12:252–260.

137. Cademartiri F, Palumbo A, Maffei E, Martini C, Malago R, Belgrano M, La Grutta L, Bartolotta TV, LuccichentiG, Midiri M, Raaijmakers R, Mollet N, Zompatori M, Crisi G. Noninvasive evaluation of the celiac trunk and superior mesenteric artery with multislice CT in patients with chronic mesenteric ischaemia. Radiol Med 2008;113:1135–1142.

138. Horton KM, Fishman EK. Multidetector CT angiography in the diagnosis of mesenteric ischemia. Radiol Clin North Am 2007;45:275–288.

139. Hellinger JC. Evaluating mesenteric ischemia with multidetector-row CT angiography. Tech Vasc Interv Radiol2004;7:160–166.

140. Laghi A, Iannaccone R, Catalano C, Passariello R. Multislice spiral computed tomography angiography of mesenteric arteries. Lancet 2001;358:638–639.

141. Otte JA, Huisman AB, Geelkerken RH, Kolkman JJ. Jejunal tonometry for the diagnosis of gastrointestinal is-chemia. Feasibility, normal values and comparison of jejunal with gastric tonometry exercise testing. Eur J Gastroenterol Hepatol 2008;20:62–67.

142. Cleveland TJ, Nawaz S, Gaines PA. Mesenteric arterial ischaemia: diagnosis and therapeutic options. Vasc Med 2002;7:311–321.

143. Cognet F, Ben Salem D, Dranssart M, Cercueil JP, Weiller M, Tatou E, Boyer L, Krause D. Chronic mesenteric ischemia: imaging and percutaneous treatment. Radiographics 2002;22:863–879; discussion 879–880.

144. Laissy JP, Trillaud H, Douek P. MR angiography: noninvasive vascular imaging of the abdomen. Abdom Imaging 2002;27:488–506.

145. Schermerhorn ML, Giles KA, Hamdan AD, Wyers MC, Pomposelli FB. Mesenteric revascularization: management and outcomes in the United States, 1988–2006. J Vasc Surg 2009;50:341–348.

146. Davies RS, Wall ML, Silverman SH, Simms MH, Vohra RK, Bradbury AW, Adam DJ. Surgical versus endovascular reconstruction for chronic mesenteric ischemia: a contemporary UK series. Vasc Endovascular Surg 2009;43:157–164.

147. Lee RW, Bakken AM, Palchik E, Saad WE, Davies MG. Long-term outcomes of endoluminal therapy for chronic atherosclerotic occlusive mesenteric disease. Ann Vasc Surg 2008;22:541–546.

148. Zerbib P, Lebuffe G, Sergent-Baudson G, Chamatan A, Massouille D, Lions C, Chambon JP. Endovascular versus open revascularization for chronic mesenteric ischemia: a comparative study. Langenbecks Arch Surg 2008;393:865–870.

149. AbuRahma AF, Stone PA, Bates MC, Welch CA. Angioplasty/stenting of the superior mesenteric artery and celiac trunk: early and late outcomes. J Endovasc Ther 2003;10:1046–1053.

150. Zeller T, Rastan A, Schwarzwalder U, Schwarz T, Frank U, Burgelin K, Sixt S, Muller C, Rothenpieler U, Flugel PC, Neumann FJ. Endovascular therapy of chronic mesenteric ischaemia. EuroIntervention 2007;2:444–451.

151. Schaefer PJ, Schaefer FK, Hinrichsen H, Jahnke T, Charalambous N, Heller M, Mueller-Huelsbeck S. Stent placement with the monorail technique for treatment of mesenteric artery stenosis. J Vasc Interv Radiol 2006;17:637–643.

152. Mell MW, Acher CW, Hoch JR, Tefera G, Turnipseed WD. Outcomes after endarterectomy for chronic mesenteric ischemia. J Vasc Surg 2008;48:1132–1138.

153. Biebl M, Oldenburg WA, Paz-Fumagalli R, McKinney JM, Hakaim AG. Surgical and interventional visceral revascularization for the treatment of chronic mesenteric ischemia—when to prefer which? World J Surg 2007;31:562–568.

154. Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med 2001;344:431–442.

155. Neymark E, LaBerge JM, Hirose R, Melzer JS, Kerlan RK Jr, Wilson MW, Gordon RL. Arteriographic detection of renovascular disease in potential renal donors: incidence and effect on donor surgery. Radiology 2000;214: 755–760.

156. De Bruyne B, Manoharan G, Pijls NH, Verhamme K, Madaric J, Bartunek J, Vanderheyden M, Heyndrickx GR. Assessment of renal artery stenosis severity by pressure gradient measurements. J Am Coll Cardiol 2006;48:1851–1855.

157. Rimmer JM, Gennari FJ. Atherosclerotic renovascular disease and progressive renal failure. Ann Intern Med1993;118:712–719.

158. Caps MT, Zierler RE, Polissar NL, Bergelin RO, Beach KW, Cantwell-Gab K, Casadei A, Davidson RC, Strandness DE Jr. Risk of atrophy in kidneys with atherosclerotic renal artery stenosis. Kidney Int 1998;53:735–742.

159. Gloviczki ML, Glockner JF, Lerman LO, McKusick MA, Misra S, Grande JP, Textor SC. Preserved oxygenation de spite reduced blood flow in poststenotic kidneys in human atherosclerotic renal artery stenosis. Hypertension 2010;55:961–966.

160. Fatica RA, Port FK, Young EW. Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States. Am J Kidney Dis 2001;37:1184–1190.

161. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296–1305.

162. Hostetter TH. Chronic kidney disease predicts cardiovascular disease. N Engl J Med 2004;351:1344–1346.

163. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study. Ann Intern Med 1989;110:101–107.

164. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561–1566.

165. Wright JR, Shurrab AE, Cooper A, Kalra PR, Foley RN, Kalra PA. Left ventricular morphology and function in patients with atherosclerotic renovascular disease. J Am Soc Nephrol 2005;16:2746–2753.

166. Greco BA, Breyer JA. The natural history of renal artery stenosis: who should be evaluated for suspected is-chemic nephropathy? Semin Nephrol 1996;16:2–11.

167. Schreiber MJ, Pohl MA, Novick AC. The natural history of atherosclerotic and fibrous renal artery disease. UrolClin North Am 1984;11:383–392.

168. Zierler RE, Bergelin RO, Davidson RC, Cantwell-Gab K, Polissar NL, Strandness DE Jr. A prospective study of disease progression in patients with atherosclerotic renal artery stenosis. Am J Hypertens 1996;9:1055–1061.

169. Jaarsveld vanBC, Krijnen P, Pieterman H, Derkx FH, Deinum J, Postma CT, Dees A, Woittiez AJ, Bartelink AK, Man in’t Veld AJ, Schalekamp MA. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med 2000;342:1007–1014.

170. Connolly JO, Higgins RM, Walters HL, Mackie AD, Drury PL, Hendry BM, Scoble JE. Presentation, clinical features and outcome in different patterns of atherosclerotic renovascular disease. QJM 1994;87:413–421.

171. White CJ, Jaff MR, Haskal ZJ, Jones DJ, Olin JW, Rocha-Singh KJ, Rosenfield KA, Rundback JH, Linas SL. Indications for renal arteriography at the time of coronary arteriography: a science advisory from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Councils on Cardiovascular Radiology and Intervention and on Kidney in Cardiovascular Disease. Circulation 2006;114:1892–1895.

172. Drieghe B, Madaric J, Sarno G, Manoharan G, Bartunek J, Heyndrickx GR, Pijls NH, De Bruyne B. Assessment of renal artery stenosis: side-by-side comparison of angiography and duplex ultrasound with pressure gradient measurements. Eur Heart J 2008;29:517–524.

173. AIUM practice guideline for the performance of renal artery duplex sonography. J Ultrasound Med 2009;28:120–124.

174. Zeller T, Bonvini RF, Sixt S. Color-coded duplex ultrasound for diagnosis of renal artery stenosis and as follow up examination after revascularization. Catheter Cardiovasc Interv 2008;71:995–999.

175. Zeller T, Frank U, Spath M, Roskamm H. [Color duplex ultrasound imaging of renal arteries and detection of hemodynamically relevant renal artery stenoses]. Ultraschall Med 2001;22:116–121.

176. Radermacher J, Weinkove R, Haller H. Techniques for predicting a favourable response to renal angioplasty in patients with renovascular disease. Curr Opin Nephrol Hypertens 2001;10:799–805.

177. Vasbinder GB, Nelemans PJ, Kessels AG, Kroon AA, Maki JH, Leiner T, Beek FJ, Korst MB, Flobbe K, de Haan MW, van Zwam WH, Postma CT, Hunink MG, de Leeuw PW, van Engelshoven JM, Renal Artery Diagnostic Imaging Study in Hypertension (RADISH) Study Group. Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis. Ann Intern Med 2004;141:674–682; discussion 682.

178. Kribben A, Witzke O, Hillen U, Barkhausen J, Daul AE, Erbel R. Nephrogenic systemic fibrosis: pathogenesis, diagnosis, and therapy. J Am Coll Cardiol 2009; 53:1621–1628.

179. Kapoor N, Fahsah I, Karim R, Jevans AJ, Leesar MA. Physiological assessment of renal artery stenosis: comparisons of resting with hyperemic renal pressure measurements. Catheter Cardiovasc Interv 2010;76:726–732.

180. Mangiacapra F, Trana C, Sarno G, Davidavicius G, Protasiewicz M, Muller O, Ntalianis A, Misonis N, Van Vlem B, Heyndrickx GR, De Bruyne B. Translesional pressure gradients to predict blood pressure response after renal artery stenting in patients with renovascular hypertension. Circ Cardiovasc Interv 2010;3:537–542.

181. Jaarsveld vanBC, Krijnen P, Derkx FH, Oei HY, Postma CT, Schalekamp MA. The place of renal scintigraphy in the diagnosis of renal artery stenosis. Fifteen years of clinical experience. Arch Intern Med 1997;157:1226–1234.

182. Mailloux LU, Napolitano B, Bellucci AG, Vernace M, Wilkes BM, Mossey RT. Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: a 20-year clinical experience. Am J Kidney Dis 1994;24:622–629.

183. Zeller T, Muller C, Frank U, Burgelin K, Schwarzwalder U, Horn B, Roskamm H, Neumann FJ. Survival after stenting of severe atherosclerotic ostial renal artery stenoses. J Endovasc Ther 2003;10:539–545.

184. Hackam DG, Duong-Hua ML, Mamdani M, Li P, Tobe SW, Spence JD, Garg AX. Angiotensin inhibition in renovascular disease: a population-based cohort study. Am Heart J 2008;156:549–555.

185. Plouin PF. Stable patients with atherosclerotic renal artery stenosis should be treated first with medical management. Am J Kidney Dis 2003;42:851–857.

186. Webster J, Marshall F, Abdalla M, Dominiczak A, Edwards R, Isles CG, Loose H, Main J, Padfield P, Russell IT, Walker B, Watson M, Wilkinson R. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens 1998;12:329–335.

187. Nordmann AJ, Logan AG. Balloon angioplasty versus medical therapy for hypertensive patients with renal artery obstruction. Cochrane Database Syst Rev 2003;3:CD002944.

188. Balk E, Raman G, Chung M, Ip S, Tatsioni A, Alonso A, Chew P, Gilbert SJ, Lau J. Effectiveness of management strategies for renal artery stenosis: a systematic review. Ann Intern Med 2006;145:901–912.

189. Gray BH, Olin JW, Childs MB, Sullivan TM, Bacharach JM. Clinical benefit of renal artery angioplasty with stenting for the control of recurrent and refractory congestive heart failure. Vasc Med 2002;7:275–279.

190. Kane GC, Xu N, Mistrik E, Roubicek T, Stanson AW, Garovic VD. Renal artery revascularization improves heart failure control in patients with atherosclerotic renal artery stenosis. Nephrol Dial Transplant 2010;25:813–820.

191. Kalra PA. Renal revascularization for heart failure in patients with atherosclerotic renovascular disease. NephrolDial Transplant 2010;25:661–663.

192. Plouin PF, Chatellier G, Darne B, Raynaud A. Blood pressure outcome of angioplasty in atherosclerotic renal ar

193. tery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension 1998;31:823–829.

194. Nordmann AJ, Woo K, Parkes R, Logan AG. Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? A meta-analysis of randomized controlled trials. Am J Med 2003;114:44–50.

195. Wheatley K, Ives N, Gray R, Kalra PA, Moss JG, Baigent C, Carr S, Chalmers N, Eadington D, Hamilton G, Lip-kin G, Nicholson A, Scoble J. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med 2009;361:1953–1962.

196. Bax L, Woittiez AJ, Kouwenberg HJ, Mali WP, Buskens E, Beek FJ, Braam B, Huysmans FT, Schultze Kool LJ, Rut-ten MJ, Doorenbos CJ, Aarts JC, Rabelink TJ, Plouin PF, Raynaud A, van Montfrans GA, Reekers JA, van den Meiracker AH, Pattynama PM, van de Ven PJ, Vroegindeweij D, Kroon AA, de Haan MW, Postma CT, Beutler JJ. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a random-ized trial. Ann Intern Med 2009;150:840–848, W150–W841.

197. Kalra PA, Chrysochou C, Green D, Cheung CM, Khavandi K, Sixt S, Rastan A, Zeller T. The benefit of renal artery stenting in patients with atheromatous renovascular disease and advanced chronic kidney disease. Catheter Cardiovasc Interv 2010;75:1–10.

198. Krishnamurthi V, Novick AC, Myles JL. Atheroembolic renal disease: effect on morbidity and survival after revascularization for atherosclerotic renal artery stenosis. J Urol 1999;161:1093–1096.

199. Scolari F, Tardanico R, Zani R, Pola A, Viola BF, Movilli E, Maiorca R. Cholesterol crystal embolism: a recognizable cause of renal disease. Am J Kidney Dis 2000;36:1089–1109.

200. Cooper CJ, Haller ST, Colyer W, Steffes M, Burket MW, Thomas WJ, Safian R, Reddy B, Brewster P, Ankenbrandt MA, Virmani R, Dippel E, Rocha-Singh K, Murphy TP, Kennedy DJ, Shapiro JI, D’Agostino RD, Pencina MJ, Khuder S. Embolic protection and platelet inhibition during renal artery stenting. Circulation 2008;117:2752–2760.

201. Bloch MJ, Trost DW, Pickering TG, Sos TA, August P. Prevention of recurrent pulmonary edema in patients with bilateral renovascular disease through renal artery stent placement. Am J Hypertens 1999;12:1–7.

202. Symonides B, Chodakowska J, Januszewicz A, Lapinski M, Januszewicz M, Rowinski O, Szmidt J, Kuch-Wocial A, Kurzyna M, Malek G, Berent H, Szmigielski C, Januszewicz W. Effects of the correction of renal artery stenosis on blood pressure, renal function and left ventricular morphology. Blood Press 1999;8:141–150.

203. Zeller T, Rastan A, Schwarzwalder U, Muller C, Frank U, Burgelin K, Sixt S, Schwarz T, Noory E, Neumann FJ. Regression of left ventricular hypertrophy following stenting of renal artery stenosis. J Endovasc Ther 2007;14:189–197.

204. Schwarzwalder U, Hauk M, Zeller T. RADAR—a randomised, multi-centre, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with haemodynamically relevant atherosclerotic renal artery stenosis. Trials 2009;10:60.

205. Sos TA, Pickering TG, Sniderman K, Saddekni S, Case DB, Silane MF, Vaughan ED Jr, Laragh JH. Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia. N Engl J Med 1983;309:274–279.

206. Slovut DP, Olin JW. Fibromuscular dysplasia. N Engl J Med 2004;350:1862–1871.

207. Davies MG, Saad WE, Peden EK, Mohiuddin IT, Naoum JJ, Lumsden AB. The long-term outcomes of percutaneous therapy for renal artery fibromuscular dysplasia. J Vasc Surg 2008;48:865–871.

208. Trinquart L, Mounier-Vehier C, Sapoval M, Gagnon N, Plouin PF. Efficacy of revascularization for renal artery stenosis caused by fibromuscular dysplasia: a systematic review and meta-analysis. Hypertension 2010;56:525–532.

209. van de Ven PJ, Kaatee R, Beutler JJ, Beek FJ, Woittiez AJ, Buskens E, Koomans HA, Mali WP. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet 1999;353:282–286.

210. Rastan A, Krankenberg H, Muller-Hulsbeck S, Sixt S, Tubler T, Muller C, Schwarzwalder U, Frank U, Schwarz T, Leppaenen O, Neumann FJ, Zeller T. Improved renal function and blood pressure control following renal artery angioplasty: the renal artery angioplasty in patients with renal insufficiency and hypertension using a dedicated renal stent device study (PRECISION). EuroIntervention 2008;4:208–213.

211. Lederman RJ, Mendelsohn FO, Santos R, Phillips HR, Stack RS, Crowley JJ. Primary renal artery stenting: characteristics and outcomes after 363 procedures. Am Heart J 2001;142:314–323.

212. Zahringer M, Sapoval M, Pattynama PM, Rabbia C, Vignali C, Maleux G, Boyer L, Szczerbo-Trojanowska M, Jaschke W, Hafsahl G, Downes M, Beregi JP, Veeger NJ, Stoll HP, Talen A. Sirolimus-eluting versus bare-metal low-profile stent for renal artery treatment (GREAT Trial): angiographic follow-up after 6 months and clinical outcome up to 2 years. J Endovasc Ther 2007;14:460–468.

213. Misra S, Thatipelli MR, Howe PW, Hunt C, Mathew V, Barsness GW, Pflueger A, Textor SC, Bjarnason H, McKu-sick MA. Preliminary study of the use of drug-eluting stents in atherosclerotic renal artery stenoses 4 mm in diameter or smaller. J Vasc Interv Radiol 2008;19:833–839.

214. Zeller T, Rastan A, Schwarzwalder U, Mueller C, Schwarz T, Frank U, Burgelin K, Sixt S, Noory E, Beschorner U, Hauswald K, Branzan D, Neumann FJ. Treatment of instent restenosis following stent-supported renal artery angioplasty. Catheter Cardiovasc Interv 2007;70:454–459.

215. N’Dandu ZM, Badawi RA, White CJ, Grise MA, Reilly JP, Jenkins JS, Collins TJ, Ramee SR. Optimal treatment of renal artery in-stent restenosis: repeat stent placement versus angioplasty alone. Catheter Cardiovasc Interv 2008;71:701–705.

216. Patel PM, Eisenberg J, Islam MA, Maree AO, Rosenfield KA. Percutaneous revascularization of persistent renal artery in-stent restenosis. Vasc Med 2009;14: 259–264.

217. Davies MG, SaadWA, Bismuth JX, Peden EK, Naoum JJ, Lumsden AB. Outcomes of endoluminal reintervention for restenosis after percutaneous renal angioplasty and stenting. J Vasc Surg 2009;49:946–952.

218. Novick AC, Ziegelbaum M, Vidt DG, Gifford RW Jr, Pohl MA, Goormastic M. Trends in surgical revascularization for renal artery disease. Ten years’ experience. JAMA 1987;257:498–501.

219. Clair DG, Belkin M, Whittemore AD, Mannick JA, Donaldson MC. Safety and efficacy of transaortic renal en-darterectomy as an adjunct to aortic surgery. J Vasc Surg 1995;21:926–933; discussion 934.

220. Cambria RP, Brewster DC, L’Italien GJ, Moncure A, Darling RC Jr, Gertler JP, La Muraglia GM, Atamian S, Ab-bott WM. The durability of different reconstructive techniques for atherosclerotic renal artery disease. J Vasc Surg 1994;20:76–85;discussion 86–77.

221. Senekowitsch C, Assadian A, Wlk MV, Assadian O, Ptakovsky H, Hagmuller GW. Renal artery surgery in the era of endovascular intervention. Vasa 2004;33:226–230.

222. Balzer KM, Pfeiffer T, Rossbach S, Voiculescu A, Modder U, Godehardt E, Sandmann W. Prospective random-ized trial of operative vs interventional treatment for renal artery ostial occlusive disease (RAOOD). J Vasc Surg 2009;49:667–674; discussion 674–665.

223. Hollenberg NK. Medical therapy of renovascular hypertension: efficacy and safety of captopril in 269 patients. Cardiovasc Rev Rep 1983;4:852–876.

224. Dorros G, Prince C, Mathiak L. Stenting of a renal artery stenosis achieves better relief of the obstructive lesion than balloon angioplasty. Cathet Cardiovasc Diagn 1993;29:191–198.

225. Zeller T, Frank U, Muller C, Burgelin K, Sinn L, Horn B, Flugel PC, Schwarzwalder U, Roskamm H, Neumann FJ. Stent-supported angioplasty of severe atherosclerotic renal artery stenosis preserves renal function and improves blood pressure control: long-term results from a prospective registry of 456 lesions. J Endovasc Ther 2004;11:95–106.

226. Zeller T, Frank U, Muller C, Burgelin K, Sinn L, Bestehorn HP, Cook-Bruns N, Neumann FJ. Predictors of improved renal function after percutaneous stentsupported angioplasty of severe atherosclerotic ostial renal artery steno-sis. Circulation 2003;108:2244–2249.

227. Korsakas S, Mohaupt MG, Dinkel HP, Mahler F, Do DD, Voegele J, Baumgartner I. Delay of dialysis in end-stage renal failure: prospective study on percutaneous renal artery interventions. Kidney Int 2004;65:251–258.

228. Leng GC, Fowkes FG. The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys. J Clin Epidemiol 1992;45:1101–1109.

229. McDermott MM, Greenland P, Liu K, Guralnik JM, Criqui MH, Dolan NC, Chan C, Celic L, Pearce WH, Schneider JR, Sharma L, Clark E, Gibson D, Martin GJ. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA 2001;286:1599–1606.

230. Lijmer JG, Hunink MG, van den Dungen JJ, Loonstra J, Smit AJ. ROC analysis of noninvasive tests for peripheral arterial disease. Ultrasound Med Biol 1996;22:391–398.

231. Stoffers HE, Kester AD, Kaiser V, Rinkens PE, Kitslaar PJ, Knottnerus JA. The diagnostic value of the measurement of the ankle–brachial systolic pressure index in primary health care. J Clin Epidemiol 1996;49:1401–1405.

232. Baker JD, Dix DE. Variability of Doppler ankle pressures with arterial occlusive disease: an evaluation of ankle index and brachial–ankle pressure gradient. Surgery 1981;89:134–137.

233. Schroder F, Diehm N, Kareem S, Ames M, Pira A, Zwettler U, Lawall H, Diehm C. A modified calculation of ankle–brachial pressure index is far more sensitive in the detection of peripheral arterial disease. J Vasc Surg 2006;44:531–536.

234. Stein R, Hriljac I, Halperin JL, Gustavson SM, Teodorescu V, Olin JW. Limitation of the resting ankle–brachial index in symptomatic patients with peripheral arterial disease. Vasc Med 2006;11:29–33.

235. Aboyans V, Ho E, Denenberg JO, Ho LA, Natarajan L, Criqui MH. The association between elevated ankle systolic pressures and peripheral occlusive arterial disease in diabetic and nondiabetic subjects. J Vasc Surg 2008;48:1197–1203.

236. Hiatt WR, Cox L, Greenwalt M, Griffin A, Schechter C. Quality of the assessment of primary and secondary endpoints in claudication and critical leg ischemia trials. Vasc Med 2005;10:207–213.

237. Ouriel K, McDonnell AE, Metz CE, Zarins CK. Critical evaluation of stress testing in the diagnosis of peripheral vascular disease. Surgery 1982;91:686–693.

238. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000;31:S1–S296.

239. Regensteiner JG, Gardner A, Hiatt WR. Exercise testing and exercise rehabilitation for patients with peripheral arterial disease: status in 1997. Vasc Med 1997;2:147–155.

240. Koelemay MJ, den Hartog D, Prins MH, Kromhout JG, Legemate DA, Jacobs MJ. Diagnosis of arterial disease of the lower extremities with duplex ultrasonography. Br J Surg 1996;83:404–409.

241. Visser K, Hunink MG. Peripheral arterial disease: gadolinium-enhanced MR angiography versus color-guided duplex US—a meta-analysis. Radiology 2000;216:67–77.

242. Collins R, Cranny G, Burch J, Aguiar-Ibanez R, Craig D, Wright K, Berry E, Gough M, Kleijnen J, Westwood M. A systematic review of duplex ultrasound, magnetic resonance angiography and computed tomography angiography for the diagnosis and assessment of symptomatic, lower limb peripheral arterial disease. Health Technol Assess 2007;11:iii–iv, xi–xiii, 1–184.

243. Winter-Warnars HA, van der Graaf Y, Mali WP. Interobserver variation in duplex sonographic scanning in the femoropopliteal tract. J Ultrasound Med 1996;15:421–428; discussion 329–430.

244. Koelemay MJ, Legemate DA, van Gurp JA, de Vos H, Balm R, Jacobs MJ. Interobserver variation of colour duplex scanning of the popliteal, tibial and pedal arteries. Eur J Vasc Endovasc Surg 2001;21:160–164.

245. Bandyk DF, Chauvapun JP. Duplex ultrasound surveillance can be worthwhile after arterial intervention. Per-spect Vasc Surg Endovasc Ther 2007;19:354–359;discussion 360–351.

246. Ferris BL, Mills JL Sr, Hughes JD, Durrani T, Knox R. Is early postoperative duplex scan surveillance of leg bypass grafts clinically important? J Vasc Surg 2003;37:495–500.

247. Ouwendijk R, de Vries M, Stijnen T, Pattynama PM, van Sambeek MR, Buth J, Tielbeek AV, van der Vliet DA, SchutzeKool LJ, Kitslaar PJ, de Haan MW, van Engelshoven JM, Hunink MG. Multicenter randomized controlled trial of the costs and effects of noninvasive diagnostic imaging in patients with peripheral arterial disease: the DIPAD trial. AJR Am J Roentgenol 2008;190:1349–1357.

248. Hingorani A, Ascher E, Marks N. Preprocedural imaging: new options to reduce need for contrast angiography. Semin Vasc Surg 2007;20:15–28.

249. Met R, Bipat S, Legemate DA, Reekers JA, Koelemay MJ. Diagnostic performance of computed tomography angiography in peripheral arterial disease: a systematic review and meta-analysis. JAMA 2009;301:415–424.

250. Poon E, Yucel EK, Pagan-Marin H, Kayne H. Iliac artery stenosis measurements: comparison of two-dimensional time-of-flight and three-dimensional dynamic gadolinium-enhanced MR angiography. AJR Am J Roentgenol 1997;169:1139–1144.

251. Ho KY, de Haan MW, Kessels AG, Kitslaar PJ, van Engelshoven JM. Peripheral vascular tree stenoses: detection with subtracted and nonsubtracted MR angiography. Radiology 1998;206:673–681.

252. Quinn SF, Sheley RC, Semonsen KG, Leonardo VJ, Kojima K, Szumowski J. Aortic and lower-extremity arterial disease: evaluation with MR angiography versus conventional angiography. Radiology 1998;206:693–701.

253. Nelemans PJ, Leiner T, de Vet HC, van Engelshoven JM. Peripheral arterial disease: meta-analysis of the diagnostic performance of MR angiography. Radiology 2000;217:105–114.

254. Koelemay MJ, Lijmer JG, Stoker J, Legemate DA, Bossuyt PM. Magnetic resonance angiography for the evaluation of lower extremity arterial disease: a meta-analysis. JAMA 2001;285:1338–1345.

255. Barnes RW. Noninvasive diagnostic assessment of peripheral vascular disease. Circulation 1991;83:I20–I27.

256. Clement DL, Van Maele GO, De Pue NY. Critical evaluation of venous occlusion plethysmography in the diagnosis of occlusive arterial diseases in the lower limbs. Int Angiol 1985;4:69–74.

257. Watson L, Ellis B, Leng GC. Exercise for intermittent claudication. Cochrane Database Syst Rev 2008;4:CD000990.

258. Gardner AW, Poehlman ET. Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis. JAMA 1995;274:975–980.

259. Bendermacher BL, Willigendael EM, Teijink JA, Prins MH. Supervised exercise therapy versus non-supervised

260. exercise therapy for intermittent claudication. Cochrane Database Syst Rev 2006;2:CD005263.

261. Hiatt WR, Wolfel EE, Meier RH, Regensteiner JG. Superiority of treadmill walking exercise versus strength training for patients with peripheral arterial disease. Implications for the mechanism of the training response. Circulation 1994;90:1866–1874.

262. Hodges LD, Sandercock GR, Das SK, Brodie DA. Randomized controlled trial ofsupervised exercise to evaluate changes in cardiac function in patients with peripheral atherosclerotic disease. Clin Physiol Funct Imaging 2008;28:32–37.

263. Claeys R, Bogaert M, Clement D. Study on the non-drug, conservative treatment of intermittent claudication. T Geneeskunde 1982;38:585–588.

264. Treat-Jacobson D, Bronas UG, Leon AS. Efficacy of arm-ergometry versus treadmill exercise training to improve walking distance in patients with claudication. Vasc Med 2009;14:203–213.

265. Pande RL, Hiatt WR, Zhang P, Hittel N, Creager MA, McDermott M. A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication. Vasc Med 2010;15:181–188.

266. Momsen AH, Jensen MB, Norager CB, Madsen MR, Vestersgaard-Andersen T,Lindholt JS. Drug therapy for improving walking distance in intermittent claudication: a systematic review and meta-analysis of robust randomised controlled studies. Eur J Vasc Endovasc Surg 2009;38:463–474.

267. O’Donnell ME, Badger SA, Sharif MA, Young IS, Lee B, Soong CV. The vascular and biochemical effects of cilostazol in patients with peripheral arterial disease. J Vasc Surg 2009;49:1226–1234.

268. Lehert P, Comte S, Gamand S, Brown TM. Naftidrofuryl in intermittent claudication: a retrospective analysis. J Cardiovasc Pharmacol 1994;23 Suppl 3:S48–S52.

269. De Backer T, Vander Stichele R, Lehert P, Van Bortel L. Naftidrofuryl for intermittent claudication: meta-analysis based on individual patient data. BMJ 2009; 338:b603.

270. Spengel F, Clement D, Boccalon H, Liard F, Brown T, Lehert P. Findings of the Naftidrofuryl in Quality of Life (NIQOL) European study program. Int Angiol 2002;21:20–27.

271. Brevetti G, Diehm C, Lambert D. European multicenter study on propionyl-L-carnitine in intermittent claudication. J Am Coll Cardiol 1999;34:1618–1624.

272. Hiatt WR, Regensteiner JG, Creager MA, Hirsch AT, Cooke JP, Olin JW, Gorbunov GN, Isner J, Lukjanov YV, Tsitsiashvili MS, Zabelskaya TF, Amato A. Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication. Am J Med 2001;110:616–622.

273. Leizorovicz A, Becker F. Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study. Circulation 2008;117:816–822.

274. de Backer TL, Bogaert M, Vander Stichele R. Buflomedil for intermittent claudication. Cochrane Database Syst Rev 2008;1:CD000988.

275. De Backer TL, Vander Stichele RH, Van Bortel LM. Bias in benefit–risk appraisal in older products: the case of buflomedil for intermittent claudication. Drug Saf 2009;32:283–291.

276. De Buyzere ML, Clement DL. Management of hypertension in peripheral arterial disease. Prog Cardiovasc Dis 2008;50:238–263.

277. Shahin Y, Mazari F, Chetter I. Do angiotensin converting enzyme inhibitors improve walking distance in patients with symptomatic lower limb arterial disease? A systematic review and meta-analysis of randomised controlled trials. Int J Surg 2011;9:209–213.

278. Bogaert MG, Clement DL. Lack of influence of propranolol and metoprolol on walking distance in patients with chronic intermittent claudication. Eur Heart J 1983;4:203–204.

279. Paravastu SC, Mendonca DA, da Silva A. Beta blockers for peripheral arterial disease. Eur J Vasc Endovasc Surg 2009;38:66–70.

280. Nicolai SP, Kruidenier LM, Bendermacher BL, Prins MH, Teijink JA. Ginkgo biloba for intermittent claudication. Cochrane Database Syst Rev 2009;2:CD006888.

281. Labropoulos N, Wierks C, Suffoletto B. Intermittent pneumatic compression for the treatment of lower extremity arterial disease: a systematic review. Vasc Med 2002;7:141–148.

282. de Haro J, Acin F, Florez A, Bleda S, Fernandez JL. A prospective randomized controlled study with intermittent mechanical compression of the calf in patients with claudication. J Vasc Surg 2010;51:857–862.

283. Diehm N, Baumgartner I, Jaff M, Do DD, Minar E, Schmidli J, Diehm C, Biamino G, Vermassen F, Scheinert D, van Sambeek MR, Schillinger M. A call for uniform reporting standards in studies assessing endovascular treatment for chronic ischaemia of lower limb arteries. Eur Heart J 2007;28:798–805.

284. Spronk S, Bosch JL, den Hoed PT, Veen HF, Pattynama PM, Hunink MG. Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital-based exercise training—randomized controlled trial. Radiology 2009;250:586–595.

285. Klein WM, van der Graaf Y, Seegers J, Moll FL, Mali WP. Long-term cardiovascular morbidity, mortality, and rein-tervention after endovascular treatment in patients with iliac artery disease: The Dutch Iliac Stent Trial Study. Radiology 2004;232:491–498.

286. Bosch JL, Hunink MG. Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease. Radiology 1997;204:87–96.

287. Kashyap VS, Pavkov ML, Bena JF, Sarac TP, O’Hara PJ, Lyden SP, Clair DG. The management of severe aortoiliac occlusive disease: endovascular therapy rivals open reconstruction. J Vasc Surg 2008;48:1451–1457.

288. Grenacher L, Rohde S, Ganger E, Deutsch J, Kauffmann GW, Richter GM. In vitro comparison of self-expanding versus balloon-expandable stents in a human ex vivo model. Cardiovasc Intervent Radiol 2006;29:249–254.

289. Tetteroo E, van der Graaf Y, Bosch JL, van Engelen AD, Hunink MG, Eikelboom BC, Mali WP. Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac-artery occlusive disease. Dutch Iliac Stent Trial Study Group. Lancet 1998;351:1153–1159.

290. Schillinger M, Sabeti S, Dick P, Amighi J, Mlekusch W, Schlager O, Loewe C, Cejna M, Lammer J, Minar E. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 2007;115:2745–2749.

291. Dick P,Wallner H, Sabeti S, Loewe C, Mlekusch W, Lammer J, Koppensteiner R, Minar E, Schillinger M. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. Catheter Cardiovasc Interv 2009;74:1090–1095.

292. Scheinert D, Scheinert S, Sax J, Piorkowski C, Braunlich S, Ulrich M, Biamino G, Schmidt A. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 2005;45:312–315.

293. Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Oliva V, Tielbeek A, Anderson J, Wiesinger B, Tepe G, Lan-sky A, Jaff MR, Mudde C, Tielemans H, Beregi JP. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther 2006;13:701–710.

294. Tepe G, Zeller T, Albrecht T, Heller S, Schwarzwalder U, Beregi JP, Claussen CD, Oldenburg A, Scheller B, Speck U. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med 2008;358: 689–699.

295. Kedora J, Hohmann S, Garrett W, Munschaur C, Theune B, Gable D. Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral–popliteal bypass in the treatment of superficial femoral arterial occlusive disease. J Vasc Surg 2007;45:10–16.

296. Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, Dave R, Ansel G, Lansky A, Cristea E, Collins TJ, Goldstein J, Jaff MR; RESILIENTInvestigators. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv 2010;3:267–276.

297. Ferraresi R, Centola M, Ferlini M, Da Ros R, Caravaggi C, Assaloni R, Sganzaroli A, Pomidossi G, Bonanomi C, Danzi GB. Long-term outcomes after angioplasty of isolated, below-the-knee arteries in diabetic patients with critical limb ischaemia. Eur J Vasc Endovasc Surg 2009;37:336–342.

298. Conrad MF, Kang J, Cambria RP, Brewster DC, Watkins MT, Kwolek CJ, LaMuraglia GM. Infrapopliteal balloon angioplasty for the treatment of chronic occlusive disease. J Vasc Surg 2009;50:799–805.

299. Siablis D, Karnabatidis D, Katsanos K, Diamantopoulos A, Spiliopoulos S, Kagadis GC, Tsolakis J. Infrapopliteal application of sirolimus-eluting versus bare metal stents for critical limb ischemia: analysis of long-term an-giographic and clinical outcome. J Vasc Interv Radiol 2009;20:1141–1150.

300. Chiu KW, Davies RS, Nightingale PG, Bradbury AW, Adam DJ. Review of direct anatomical open surgical management of atherosclerotic aorto-iliac occlusive disease. Eur J Vasc Endovasc Surg 2010;39:460–471.

301. Twine CP, McLain AD. Graft type for femoro-popliteal bypass surgery. Cochrane Database Syst Rev 2010;5:CD001487.

302. Griffiths GD, Nagy J, Black D, Stonebridge PA. Randomized clinical trial of distal anastomotic interposition vein cuff in infrainguinal polytetrafluoroethylene bypass grafting. Br J Surg 2004;91:560–562.

303. SCAMICOS. PTFE bypass to below-knee arteries: distal vein collar or not? A prospective randomised multicentre study. Eur J Vasc Endovasc Surg 2010;39:747–754.

304. Takagi H, Goto SN, Matsui M, Manabe H, Umemoto T. A contemporary meta-analysis of Dacron versus polytetrafluoroethylene grafts for femoropopliteal bypass grafting. J Vasc Surg 2010;52:232–236.

305. Johnson WC, Lee KK. A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral–popliteal aboveknee revascularization: a prospective randomized Department of Veterans Affairs cooperative study. J Vasc Surg 2000;32:268–277.

306. Bradbury AW, Adam DJ, Bell J, Forbes JF, Fowkes FG, Gillespie I, Ruckley CV, Raab GM; BASIL TrialParticipants. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J Vasc Surg 2010;51:5S–17S.

307. Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, Fowkes FG, Gillepsie I, Ruckley CV, Raab G, Storkey H. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005;366:1925–1934.

308. Bradbury AW, Adam DJ, Bell J, Forbes JF, Fowkes FG, Gillespie I, Ruckley CV, Raab GM; BASIL TrialParticipants. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: a survival prediction model to facilitate clinical decision making. J Vasc Surg 2010;51:52S–68S.

309. Diehm N, Schillinger M, Minar E, Gretener S, Baumgartner I. TASC II section E3 on the treatment of acute limb ischemia: commentary from European interventionists. J Endovasc Ther 2008;15:126–128.

310. Bandyk DF. Surveillance after lower extremity arterial bypass. Perspect Vasc Surg Endovasc Ther 2007;19:376–383.

311. Davies AH, Hawdon AJ, Sydes MR, Thompson SG; VGSTParticipants. Is duplex surveillance of value after leg vein bypass grafting? Principal results of the Vein Graft Surveillance Randomised Trial (VGST). Circulation 2005;112:1985–1991.

312. Brumberg RS, Back MR, Armstrong PA, Cuthbertson D, Shames ML, Johnson BL, Bandyk DF. The relative importance of graft surveillance and warfarin therapy in infrainguinal prosthetic bypass failure. J Vasc Surg 2007;46:1160–1166.

313. Brown J, Lethaby A, Maxwell H, Wawrzyniak AJ, Prins MH. Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery. Cochrane Database Syst Rev 2008;4:CD000535.

314. Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral Anticoagulants or Aspirin Study): a randomised trial. Lancet 2000;355:346–351.

315. Johnson WC, Williford WO; Department of Veterans Affairs Cooperative Study #362. Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass procedures: a prospective randomized study. J Vasc Surg 2002;35:413–421.

316. Sarac TP, Huber TS, Back MR, Ozaki CK, Carlton LM, Flynn TC, Seeger JM.Warfarin improves the outcome of infrainguinal vein bypass grafting at high risk for failure. J Vasc Surg 1998;28:446–457.

317. Belch JJ, Dormandy J, CASPAR Writing Committee, Biasi BM, Cairols M, Diehm C, Eikelboom B, Golledge J, Jawien A, Lepantalo M, Norgren L, Hiatt WR, Becquemin JP, Bergqvist D, Clement D, Baumgartner I, Minar E, Stonebridge P, Vermassen F, Matyas L, Leizorovicz A. Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. J Vasc Surg 2010;52:825–833, 833 e821–822.

318. Dagher NN, Modrall JG. Pharmacotherapy before and after revascularization: anticoagulation, antiplatelet agents, and statins. Semin Vasc Surg 2007;20:10–14.

319. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, Amano K, Kishimoto Y, Yoshimoto K, Akashi H, Shimada K, Iwasaka T, Imaizumi T. Therapeutic angiogenesis for patients with limb is-chaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002;360:427–435.

320. Kusumanto YH, van Weel V, Mulder NH, Smit AJ, van den Dungen JJ, Hooymans JM, Sluiter WJ, Tio RA, Quax PH, Gans RO, Dullaart RP, Hospers GA. Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind random-ized trial. Hum Gene Ther 2006;17:683–691.

321. Nikol S, Baumgartner I, Van Belle E, Diehm C, Visona A, Capogrossi MC, Ferreira-Maldent N, Gallino A, Wyatt MG, Wijesinghe LD, Fusari M, Stephan D, Emmerich J, Pompilio G, Vermassen F, Pham E, Grek V, Coleman M, Meyer F. Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia. Mol Ther 2008;16:972–978.

322. Shigematsu H, Yasuda K, Iwai T, Sasajima T, Ishimaru S, Ohashi Y, Yamaguchi T, Ogihara T, Morishita R. Ran-domized, double-blind, placebo-controlled clinical trial of hepatocyte growth factor plasmid for critical limb ischemia. Gene Ther 2010;17:1152–1161.

323. Rajagopalan S, Mohler ER 3rd, Lederman RJ, Mendelsohn FO, Saucedo JF, Goldman CK, Blebea J, Macko J, Kessler PD, Rasmussen HS, Annex BH. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation 2003;108:1933–1938.

324. Grossman PM, Mendelsohn F, Henry TD, Hermiller JB, Litt M, Saucedo JF, Weiss RJ, Kandzari DE, Kleiman N, Anderson RD, Gottlieb D, Karlsberg R, Snell J, Rocha-Singh K. Results from a phase II multicenter, double-blind placebocontrolled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease. Am Heart J 2007;153:874–880.

325. Huang PP, Yang XF, Li SZ, Wen JC, Zhang Y, Han ZC. Randomised comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrowmononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans. Thromb Haemost 2007;98:1335–1342.

326. Sprengers RW, Moll FL, Verhaar MC. Stem cell therapy in PAD. Eur J Vasc Endovasc Surg 2010;39 Suppl1:S38–S43.

327. Belch J, Hiatt WR, Baumgartner I, Driver IV, Nikol S, Norgren L, Van Belle E; on behalf of the TAMARIS Committees and Investigators. Effect of fibroblast growth factor NV1FGF on amputation and death: a randomized placebocontrolled trial of gene therapy in critical limb ischaemia. Lancet 2011;377:1929–1937.

328. Whyman MR, Fowkes FG, Kerracher EM, Gillespie IN, Lee AJ, Housley E, Ruckley CV. Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial. J Vasc Surg 1997;26:551–557.

329. Greenhalgh RM, Belch JJ, Brown LC, Gaines PA, Gao L, Reise JA, Thompson SG. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. Eur J Vasc Endovasc Surg 2008;36:680–688.

330. Murphy TP, Hirsch AT, Ricotta JJ, Cutlip DE, Mohler E, Regensteiner JG, Comerota AJ, Cohen DJ; CLEVER Steering Committee. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. J Vasc Surg 2008;47:1356–1363.

331. Diehm C, Lange S, Darius H, Pittrow D, von Stritzky B, Tepohl G, Haberl RL, Allenberg JR, Dasch B, Trampisch HJ. Association of low ankle brachial index with high mortality in primary care. Eur Heart J 2006;27:1743–1749.

332. Slovut DP, Sullivan TM. Critical limb ischemia: medical and surgical management. Vasc Med 2008;13:281–291.

333. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, Jones DN. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 1997;26:517–538.

334. Heart Protection Study Collaborative Group. Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg 2007;45:645–654.

335. Catalano M, Born G, Peto R. Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double-blind trial. J Intern Med 2007;261:276–284.

336. Dick F, Diehm N, Galimanis A, Husmann M, Schmidli J, Baumgartner I. Surgical or endovascular revascularization in patients with critical limb ischemia: influence of diabetes mellitus on clinical outcome. J Vasc Surg 2007;45:751–761.

337. Lawrence PF, Chandra A. When should open surgery be the initial option for critical limb ischaemia? Eur J VascEndovasc Surg 2010;39 Suppl 1:S32–S37.

338. Van Damme H, Zhang L, Baguet E, Creemers E, Albert A, Limet R. Crural artery bypass with the autogenous greater saphenous vein. Eur J Vasc Endovasc Surg 2003;26:635–642.

339. Pomposelli FB, Kansal N, Hamdan AD, Belfield A, Sheahan M, Campbell DR, Skillman JJ, Logerfo FW. A decade of experience with dorsalis pedis artery bypass: analysis of outcome in more than 1000 cases. J Vasc Surg 2003;37:307–315.

340. Conte MS, Geraghty PJ, Bradbury AW, Hevelone ND, Lipsitz SR, Moneta GL, Nehler MR, Powell RJ, Sidawy AN. Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia. J Vasc Surg 2009;50:1462–1473.

341. Wolfe JH, Wyatt MG. Critical and subcritical ischaemia. Eur J Vasc Endovasc Surg 1997;13:578–582.

342. Taylor SM, Cull DL, Kalbaugh CA, Cass AL, Harmon SA, Langan EM 3rd, Youkey JR. Critical analysis of clinical success after surgical bypass for lowerextremity ischemic tissue loss using a standardized definition combining multiple parameters: a new paradigm of outcomes assessment. J Am Coll Surg 2007;204:831–838.

343. Dormandy JA. Prostanoid drug therapy for peripheral arterial occlusive disease—the European experience. Vasc Med 1996;1:155–158.

344. Creutzig A, LehmacherW, Elze M. Meta-analysis of randomised controlled prostaglandin E1 studies in peripheral arterial occlusive disease stages III and IV. Vasa 2004;33:137–144.

345. Ruffolo AJ, Romano M, Ciapponi A. Prostanoids for critical limb ischaemia. Cochrane Database Syst Rev 2010;1:CD006544.

346. Ubbink DT, Vermeulen H. Spinal cord stimulation for non-reconstructable chronic critical leg ischaemia. Cochrane Database Syst Rev 2005;3:CD004001.

347. Sobel M, Verhaeghe R. Antithrombotic therapy for peripheral artery occlusive disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:815S–843S.

348. Ouriel K, Shortell CK, DeWeese JA, Green RM, Francis CW, Azodo MV, Gutierrez OH, Manzione JV, Cox C, Marder VJ. A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia. J Vasc Surg 1994;19:1021–1030.

349. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial. Ann Surg 1994;220:251–266.

350. Ouriel K, Veith FJ, Sasahara AA. A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators. N Engl J Med 1998;338:1105–1111.

351. Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D, Vahanian A, Auricchio A, Bax J, Ceconi C, Dean V, Filippatos G, Funck-Brentano C, Hobbs R, Kearney P, McDonagh T, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas PE, Widimsky P, Alfieri O, Dunning J, Elia S, Kappetein P, Lockowandt U, Sarris G, Vouhe P, von Segesser L, Agewall S, Aladashvili A, Alexopoulos D, Antunes MJ, Atalar E, Brutel de la Riviere A, Doganov A, Eha J, Fajadet J, Ferreira R, Garot J, Halcox J, Hasin Y, Janssens S, Kervinen K, Laufer G, Legrand V, Nashef SA, Neumann FJ, Niemela K, Nihoyannopoulos P, Noc M, Piek JJ, Pirk J, Rozenman Y, Sabate M, Starc R, Thielmann M, Wheatley DJ, Windecker S, Zembala M. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Car-dio-Thoracic Surgery (EACTS). Eur Heart J 2010;31:2501–2555.

352. Cupples LA, Gagnon DR, Wong ND, Ostfeld AM, Kannel WB. Preexisting cardiovascular conditions and longterm prognosis after initial myocardial infarction: the Framingham Study. Am Heart J 1993;125:863–872.

353. Alberts MJ, Bhatt DL, Mas JL, Ohman EM, Hirsch AT, Rother J, Salette G, Goto S, Smith SC Jr, Liau CS, Wilson PW, Steg PG; REduction of Atherothrombosis for Continued Health Registry Investigators. Three-year followup and event rates in the international REduction of Atherothrombosis for Continued Health Registry. Eur Heart J 2009;30:2318–2326.

354. Ferrieres J, Cambou JP, Gayet JL, Herrmann MA, Leizorovicz A. Prognosis of patients with atherothrombotic disease: a prospective survey in a non-hospital setting. Int J Cardiol 2006;112:302–307.

355. Aboyans V, Lacroix P. Indications for carotid screening in patients with coronary artery disease. Presse Med 2009;38:977–986.

356. Blacker DJ, Flemming KD, Link MJ, Brown RD Jr. The preoperative cerebrovascular consultation: common cerebrovascular questions before general or cardiac surgery. Mayo Clin Proc 2004;79:223–229.

357. Aboyans V, Lacroix P, Guilloux J, Rolle F, Le Guyader A, Cautres M, Cornu E, Laskar M. A predictive model for screening cerebrovascular disease in patient undergoing coronary artery bypass grafting. Interact Cardiovasc Thorac Surg 2005;4:90–95.

358. Brown KR, Kresowik TF, Chin MH, Kresowik RA, Grund SL, Hendel ME. Multistate population-based outcomes of combined carotid endarterectomy and coronary artery bypass. J Vasc Surg 2003;37:32–39.

359. Selim M. Perioperative stroke. N Engl J Med 2007;356:706–713.

360. Naylor R, Cuffe RL, Rothwell PM, Loftus IM, Bell PR. A systematic review of outcome following synchronous carotid endarterectomy and coronary artery bypass: influence of surgical and patient variables. Eur J Vasc En-dovasc Surg 2003;26:230–241.

361. Kolh PH, Comte L, Tchana-Sato V, Honore C, Kerzmann A, Mauer M, Limet R. Concurrent coronary and carotid artery surgery: factors influencing perioperative outcome and long-term results. Eur Heart J 2006;27:49–56.

362. Hill MD, Shrive FM, Kennedy J, Feasby TE, Ghali WA. Simultaneous carotid endarterectomy and coronary artery bypass surgery in Canada. Neurology 2005;64:1435–1437.

363. Dubinsky RM, Lai SM. Mortality from combined carotid endarterectomy and coronary artery bypass surgery in the US. Neurology 2007;68:195–197.

364. Byrne J, Darling RC 3rd, Roddy SP, Mehta M, Paty PS, Kreienberg PB, Chang BB, Ozsvath KJ, Shah DM. Combined carotid endarterectomy and coronary artery bypass grafting in patients with asymptomatic high-grade stenoses: an analysis of 758 procedures. J Vasc Surg 2006;44:67–72.

365. Char D, Cuadra S, Ricotta J, Bilfinger T, Giron F, McLarty A, Krukenkamp I, Saltman A, Seifert F. Combined coronary artery bypass and carotid endarterectomy: long-term results. Cardiovasc Surg 2002;10:111–115.

366. Cywinski JB, Koch CG, Krajewski LP, Smedira N, Li L, Starr NJ. Increased risk associated with combined carotid endarterectomy and coronary artery bypass graft surgery: a propensity-matched comparison with isolated coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2006;20:796–802.

367. Ricotta JJ, Wall LP, Blackstone E. The influence of concurrent carotid endarterectomy on coronary bypass: a case-controlled study. J Vasc Surg 2005;41: 397–401; discussion 401–392.

368. Timaran CH, Rosero EB, Smith ST, Valentine RJ, Modrall JG, Clagett GP. Trends and outcomes of concurrent carotid revascularization and coronary bypass. J Vasc Surg 2008;48:355–361.

369. Ziada KM, Yadav JS, Mukherjee D, Lauer MS, Bhatt DL, Kapadia S, Roffi M, Vora N, Tiong I, Bajzer C. Comparison of results of carotid stenting followed by open heart surgery versus combined carotid endarterectomy and open heart surgery (coronary bypass with or without another procedure). Am J Cardiol 2005;96:519–523.

370. Kovacic JC, Roy PR, Baron DW, Muller DW. Staged carotid artery stenting and coronary artery bypass graft surgery: initial results from a single center. Catheter Cardiovasc Interv 2006;67:142–148.

371. Randall MS, McKevitt FM, Cleveland TJ, Gaines PA, Venables GS. Is there any benefit from staged carotid and coronary revascularization using carotid stents? A single-center experience highlights the need for a random-ized controlled trial. Stroke 2006;37:435–439.

372. Mendiz O, Fava C, Valdivieso L, Dulbecco E, Raffaelli H, Lev G, Favaloro R. Synchronous carotid stenting and cardiac surgery: an initial single-center experience. Catheter Cardiovasc Interv 2006;68:424–428.

373. Van der Heyden J, Suttorp MJ, Bal ET, Ernst JM, Ackerstaff RG, Schaap J, Kelder JC, Schepens M, Plokker HW. Staged carotid angioplasty and stenting followed by cardiac surgery in patients with severe asymptomatic carotid artery stenosis: early and long-term results. Circulation 2007;116:2036–2042.

374. Ghosh J, Murray D, Khwaja N, Murphy MO, Walker MG. The influence of asymptomatic significant carotid disease on mortality and morbidity in patients undergoing coronary artery bypass surgery. Eur J Vasc Endovasc Surg 2005;29:88–90.

375. Naylor AR, Mehta Z, Rothwell PM. A systematic review and meta-analysis of 30-day outcomes following staged carotid artery stenting and coronary bypass. Eur J Vasc Endovasc Surg 2009;37:379–387.

376. Van der Heyden J, Lans HW, van Werkum JW, Schepens M, Ackerstaff RG, Suttorp MJ. Will carotid angioplasty become the preferred alternative to staged or synchronous carotid endarterectomy in patients undergoing cardiac surgery? Eur J Vasc Endovasc Surg 2008;36:379–384.

377. Guzman LA, Costa MA, Angiolillo DJ, Zenni M, Wludyka P, Silliman S, Bass TA. A systematic review of outcomes in patients with staged carotid artery stenting and coronary artery bypass graft surgery. Stroke 2008;39:361–365.

378. Wiesmann M, Schopf V, Jansen O, Bruckmann H. Stent-protected angioplasty versus carotid endarterectomy in patients with carotid artery stenosis: meta-analysis of randomized trial data. Eur Radiol 2008;18:2956–2966.

379. Versaci F, Reimers B, Del Giudice C, Schofer J, Giacomin A, Sacca S, Gandini R, Albiero R, Pellegrino A, Bertoldo F, Simonetti G, Chiariello L. Simultaneous hybrid revascularization by carotid stenting and coronary artery bypass grafting: the SHARP study. JACC Cardiovasc Interv 2009;2:393–401.

380. Park S, Jung JH, Seo HS, Ko YG, Choi D, Jang Y, Chung N, Cho SY, Shim WH. The prevalence and clinical predictors of atherosclerotic renal artery stenosis in patients undergoing coronary angiography. Heart Vessels 2004;19:275–279.

381. Zhang Y, Ge JB, Qian JY, Ye ZB. Prevalence and risk factors of atherosclerotic renal artery stenosis in 1,200Chinese patients undergoing coronary angiography. Nephron Clin Pract 2006;104:c185–c192.

382. Harding MB, Smith LR, Himmelstein SI, Harrison K, Phillips HR, Schwab SJ, Hermiller JB, Davidson CJ, Bashore TM. Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol 1992;2:1608–1616.

383. Gross CM, Kramer J, Waigand J, Luft FC, Dietz R. Relation between arteriosclerosis in the coronary and renal arteries. Am J Cardiol 1997;80:1478–1481.

384. Przewlocki T, Kablak-Ziembicka A, Tracz W, Kozanecki A, Kopec G, Rubis P, Kostkiewicz M, Roslawiecka A, Rzeznik D, Stompor T. Renal artery stenosis in patients with coronary artery disease. Kardiol Pol 2008;66:856–862; discussion 863–854.

385. Tumelero RT, Duda NT, Tognon AP, Thiesen M. Prevalence of renal artery stenosis in 1,656 patients who have undergone cardiac catheterization. Arq Bras Cardiol 2006;87:248–253.

386. Kownator S, Cambou JP, Cacoub P, Leger P, Luizy F, Herrmann MA, Priollet P. Prevalence of unknown peripheral arterial disease in patients with coronary artery disease: data in primary care from the IPSILON study. Arch Cardiovasc Dis 2009;102:625–631.

387. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, McDermott MM, Hiatt WR. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001;286:1317–1324.

388. Agnelli G, Cimminiello C, Meneghetti G, Urbinati S; Polyvascular Atherothrombosis Observational Survey Investigators. Low ankle–brachial index predicts an adverse 1-year outcome after acute coronary and cerebrovascular events. J Thromb Haemost 2006;4:2599–2606.

389. Poredos P, Jug B. The prevalence of peripheral arterial disease in high risk subjects and coronary or cerebrovascular patients. Angiology 2007;58:309–315.

390. Hayoz D, Bounameaux H, Canova CR. Swiss Atherothrombosis Survey: a field report on the occurrence of symptomatic and asymptomatic peripheral arterial disease. J Intern Med 2005;258:238–243.

391. Eagle KA, Rihal CS, Foster ED, Mickel MC, Gersh BJ. Long-term survival in patients with coronary artery disease: importance of peripheral vascular disease. The Coronary Artery Surgery Study (CASS) Investigators. J Am Coll Cardiol 1994;23:1091–1095.

392. Behar S, Zion M, Reicher-Reiss H, Kaplinsky E, Goldbourt U. Short- and longterm prognosis of patients with a first acute myocardial infarction with concomitant peripheral vascular disease. SPRINT Study Group. Am J Med 1994;96:15–19.

393. Makowsky MJ, McAlister FA, Galbraith PD, Southern DA, Ghali WA, Knudtson ML, Tsuyuki RT; Alberta Provincial Program for Outcome Assessment in Coronary Heart Disease (APPROACH) Investigators. Lower extremity peripheral arterial disease in individuals with coronary artery disease: prognostic importance, care gaps, and impact of therapy. Am Heart J 2008;155:348–355.

394. Brevetti G, Oliva G, Silvestro A, Scopacasa F, Chiariello M. Prevalence, risk factors and cardiovascular comorbidity of symptomatic peripheral arterial disease in Italy. Atherosclerosis 2004;175:131–138.

395. Mukherjee D, Eagle KA, Kline-Rogers E, Feldman LJ, Juliard JM, Agnelli G, Budaj A, Avezum A, Allegrone J, FitzGerald G, Steg PG. Impact of prior peripheral arterial disease and stroke on outcomes of acute coronary syndromes and effect of evidence-based therapies (from the Global Registry of Acute Coronary Events). Am J Cardiol 2007;100:1–6.

396. Leger P, Ferrieres J, Cantie P, Cambou JP, Ruidavets JB, Tarabbia P, Berdague P, Boccalon H. [Chronic obliterative arterial disease of the lower limbs in the coronary patient: prevalence and prognostic incidence. The Monica Toulouse register]. Rev Med Interne 1999;20:404–407.

397. Saw J, Bhatt DL, Moliterno DJ, Brener SJ, Steinhubl SR, Lincoff AM, Tcheng JE, Harrington RA, Simoons M, Hu T, Sheikh MA, Kereiakes DJ, Topol EJ. The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials. J Am Coll Cardiol 2006;48:1567–1572.

398. Rihal CS, Sutton-Tyrrell K, Guo P, Keller NM, Jandova R, Sellers MA, Schaff HV, Holmes DR Jr. Increased incidence of periprocedural complications among patients with peripheral vascular disease undergoing myocardial revascularization in the bypass angioplasty revascularization investigation. Circulation 1999;100:171–177.

399. Aboyans V, Lacroix P, Postil A, Guilloux J, Rolle F, Cornu E, Laskar M. Subclinical peripheral arterial disease and incompressible ankle arteries are both long-term prognostic factors in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 2005;46:815–820.

400. Monaco M, Stassano P, Di Tommaso L, Pepino P, Giordano A, Pinna GB, Iannelli G, Ambrosio G. Systematic strategy of prophylactic coronary angiography improves long-term outcome after major vascular surgery in medium- to high-risk patients: a prospective, randomized study. J Am Coll Cardiol 2009;54:989–996.

401. McFalls EO, Ward HB, Moritz TE, Goldman S, Krupski WC, Littooy F, Pierpont G, Santilli S, Rapp J, Hattler B, Shunk K, Jaenicke C, Thottapurathu L, Ellis N, Reda DJ, Henderson WG. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 2004;351:2795–2804.

402. Poldermans D, Schouten O, Vidakovic R, Bax JJ, Thomson IR, Hoeks SE, Feringa HH, Dunkelgrun M, de Jaegere P, Maat A, van Sambeek MR, Kertai MD, Boersma E; DECREASE Study Group. A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study. J Am Coll Cardiol 2007;49:1763–1769.

403. Hertzer NR, Young JR, Beven EG, Graor RA, O’Hara PJ, Ruschhaupt WF 3rd, deWolfe VG, Maljovec LC. Coronary angiography in 506 patients with extracranial cerebrovascular disease. Arch Intern Med 1985;145:849–852.

404. Hofmann R, Kypta A, Steinwender C, Kerschner K, Grund M, Leisch F. Coronary angiography in patients undergoing carotid artery stenting shows a high incidence of significant coronary artery disease. Heart 2005;91:1438–1441.

405. Illuminati G, Ricco JB, Greco C, Mangieri E, Calio F, Ceccanei G, Pacile MA, Schiariti M, Tanzilli G, Barilla F, Par-avati V, Mazzesi G, Miraldi F, Tritapepe L. Systematic preoperative coronary angiography and stenting improves postoperative results of carotid endarterectomy in patients with asymptomatic coronary artery disease: a randomised controlled trial. Eur J Vasc Endovasc Surg 2010;39:139–145.

406. Hertzer NR, Beven EG, Young JR, O’Hara PJ, Ruschhaupt WF 3rd, Graor RA, Dewolfe VG, Maljovec LC. Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management. Ann Surg 1984;199:223–233.

407. Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL, Goto S, Liau CS, Richard AJ, Rother J, Wilson PW; REACH REGISTRY Investigators. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006;295:180–189.

408. Aronow WS, Ahn C. Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women, or >62 years of age. Am J Cardiol 1994;74:64–65.

409. Ness J, Aronow WS. Prevalence of coexistence of coronary artery disease, ischemic stroke, and peripheral arterial disease in older persons, mean age 80 years, in an academic hospital-based geriatrics practice. J Am Geriatr Soc 1999;47:1255–1256.

410. Lange S, Trampisch HJ, Haberl R, Darius H, Pittrow D, Schuster A, von Stritzky B, Tepohl G, Allenberg JR, Diehm C. Excess 1-year cardiovascular risk in elderly primary care patients with a low ankle–brachial index (ABI) and high homocysteine level. Atherosclerosis 2005;178:351–357.

411. Bhatt D, Eagle K, Ohman EM, Hirsch AT, S? G, Wislon PFW, D’Agostino R, Liau CS, Mas JL, Ro¨ther J, Smith SC, Salette G, Constant CF, Massaro JM, Steg PG. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. JAMA 2010;304:1350–1357.

412. Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Knudtson M, Dada M, Casperson P, Harris CL, Chaitman BR, Shaw L, Gosselin G, Nawaz S, Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, Spertus JA, Berman DS, Mancini GB, Weintraub WS; COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007;356:1503–1516.

413. Отдельная литература

414. Quinn SF, Sheley RC, Semonsen KG, Leonardo VJ, Kojima K, Szumowski J. Aortic and lower-extremity arterial disease: evaluation with MR angiography versus conventional angiography. Radiology 1998;206:693–701.

415. Nelemans PJ, Leiner T, de Vet HC, van Engelshoven JM. Peripheral arterial disease: meta-analysis of the diagnostic performance of MR angiography. Radiology 2000;217:105–114.

416. Barnes RW. Noninvasive diagnostic assessment of peripheral vascular disease. Circulation 1991;83:I20–I27.

417. Maki JH, Prince MR, Chenevert TC. Optimizing three-dimensional gadoliniumenhanced magnetic resonance angiography. Original investigation. Invest Radiol 1998;33:528–537.

418. Saloner D. Determinants of image appearance in contrast-enhanced magnetic resonance angiography. A review. Invest Radiol 1998;33:488–495.

419. Clement DL, Van Maele GO, De Pue NY. Critical evaluation of venous occlusion plethysmography in the diagnosis of occlusive arterial diseases in the lower limbs. Int Angiol 1985;4:69–74.

420. Watson L, Ellis B, Leng GC. Exercise for intermittent claudication. Cochrane Database Syst Rev 2008;4:CD000990.

421. Gardner AW, Poehlman ET. Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis. JAMA 1995;274:975–980.

422. Ruehm SG, Goyen M, Barkhausen J, Kroger K, Bosk S, Ladd ME, Debatin JF. Rapid magnetic resonance angiography for detection of atherosclerosis. Lancet 2001;357:1086–1091.

423. Goyen M, Quick HH, Debatin JF, Ladd ME, Barkhausen J, Herborn CU, Bosk S, Kuehl H, Schleputz M, Ruehm SG. Whole-body three-dimensional MR angiography with a rolling table platform: initial clinical experience. Radiology 2002;224:270–277.

424. Hiatt WR,Wolfel EE, Meier RH, Regensteiner JG. Superiority of treadmill walking exercise versus strength training for patients with peripheral arterial disease. Implications for the mechanism of the training response. Circulation 1994;90:1866–1874.

425. Hodges LD, Sandercock GR, Das SK, Brodie DA. Randomized controlled trial of supervised exercise to evaluate changes in cardiac function in patients with peripheral atherosclerotic disease. Clin Physiol Funct Imaging 2008;28:32–37.

426. Gohde SC, Goyen M, Forsting M, Debatin JF. [Prevention without radiation—a strategy for comprehensive early detection using magnetic resonance tomography]. Radiologe 2002;42:622–629.

427. Fenchel M, Scheule AM, Stauder NI, Kramer U, Tomaschko K, Nagele T, Bretschneider C, Schlemmer HP, Claussen CD, Miller S. Atherosclerotic disease: whole-body cardiovascular imaging with MR system with 32 receiver channels and total-body surface coil technology—initial clinical results. Radiology 2006;238:280–291.

428. Donnan GA, Davis SM, Chambers BR, Gates PC. Surgery for prevention of stroke. Lancet 1998;351:1372–1373.

429. Bond R, Rerkasem K, AbuRahma AF, Naylor AR, Rothwell PM. Patch angioplasty versus primary closure for carotid endarterectomy. Cochrane Database Syst Rev 2004;2:CD000160.

430. Mannheim D, Weller B, Vahadim E, Karmeli R. Carotid endarterectomy with a polyurethane patch versus primary closure: a prospective randomized study. J Vasc Surg 2005;41:403–407; discussion 407–408.

431. Cao PG, de Rango P, Zannetti S, Giordano G, Ricci S, Celani MG. Eversion versus conventional carotid endarterectomy for preventing stroke. Cochrane Database Syst Rev 2001;1:CD001921.

432. Ahmadi R, Willfort A, Lang W, Schillinger M, Alt E, Gschwandtner ME, Haumer M, Maca T, Ehringer H, Minar

433. E. Carotid artery stenting: effect of learning curve and intermediate-term morphological outcome. J Endovasc Ther 2001;8:539–546.

434. Verzini F, Cao P, De Rango P, Parlani G, Maselli A, Romano L, Norgiolini L, Giordano G. Appropriateness of learning curve for carotid artery stenting: an analysis of periprocedural complications. J Vasc Surg 2006;44:1205–1211; discussion 1211–1202.

435. Lin PH, Bush RL, Peden EK, Zhou W, Guerrero M, Henao EA, Kougias P, Mohiuddin I, Lumsden AB. Carotid artery stenting with neuroprotection: assessing the learning curve and treatment outcome. Am J Surg 2005;190:850–857.

436. Theiss W, Hermanek P, Mathias K, Bruckmann H, Dembski J, Hoffmann FJ, Kerner R, Leisch F, Mudra H, Schulte KL, Sievert H. Predictors of death and stroke after carotid angioplasty and stenting: a subgroup analysis of the Pro-CAS data. Stroke 2008;39:2325–2330.

437. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Trans-luminal Angioplasty Study (CAVATAS): a randomised trial. Lancet 2001;357:1729–1737.

438. Fiehler J, Jansen O, Berger J, Eckstein HH, Ringleb PA, Stingele R. Differences in complication rates among the centres in the SPACE study. Neuroradiology 2008;50:1049–1053.

439. Mas JL, Chatellier G, Beyssen B, Branchereau A, Moulin T, Becquemin JP, Larrue V, Lievre M, Leys D, Bonneville JF, Watelet J, Pruvo JP, Albucher JF, Viguier A, Piquet P, Garnier P, Viader F, Touze E, Giroud M, Hosseini H, Pillet JC, Favrole P, Neau JP, Ducrocq X. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 2006;355:1660–1671.

440. Ederle J, Dobson J, Featherstone RL, Bonati LH, van der Worp HB, de Borst GJ, Lo TH, Gaines P, Dorman PJ, Mac-donald S, Lyrer PA, Hendriks JM, McCollum C, Nederkoorn PJ, Brown MM. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial. Lancet 2010;375:985–997.

441. Brott TG, Hobson RW 2nd, Howard G, Roubin GS, Clark WM, Brooks W, Mackey A, Hill MD, Leimgruber PP, Sheffet AJ, Howard VJ, Moore WS, Voeks JH, Hopkins LN, Cutlip DE, Cohen DJ, Popma JJ, Ferguson RD, Cohen SN, Blackshear JL, Silver FL, Mohr JP, Lal BK, Meschia JF. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med 2010;363:11–23.

442. Roffi M, Sievert H, Gray WA, White CJ, Torsello G, Cao P, Reimers B, Mathias K, Setacci C, Schonholz C, Clair DG, Schillinger M, Grunwald I, Bosiers M, Abou-Chebl A, Moussa ID, Mudra H, Iyer SS, Scheinert D, Yadav JS, van Sambeek MR, Holmes DR, Cremonesi A. Carotid artery stenting versus surgery: adequate comparisons? Lancet Neurol 2010;9:339–341.

443. SSYLVIA Study Investigators. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke 2004;35:1388–1392.

444. Jenkins JS, Patel SN, White CJ, Collins TJ, Reilly JP, McMullan PW, Grise MA, Grant AG, Ramee SR. Endovascular stenting for vertebral artery stenosis. J Am Coll Cardiol 2010;55:538–542.

445. Plouin PF, Chatellier G, Darne B, Raynaud A. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension 1998;31:823–829.

446. Webster J, Marshall F, Abdalla M, Dominiczak A, Edwards R, Isles CG, Loose H, Main J, Padfield P, Russell IT, Walker B, Watson M, Wilkinson R. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Steno-sis Collaborative Group. J Hum Hypertens 1998;12:329–335.

447. van de Ven PJ, Kaatee R, Beutler JJ, Beek FJ,Woittiez AJ, Buskens E, Koomans HA, Mali WP. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet 1999;353:282–286.

448. van Jaarsveld BC, Krijnen P, Pieterman H, Derkx FH, Deinum J, Postma CT, Dees A, Woittiez AJ, Bartelink AK, Man in ’t Veld AJ, Schalekamp MA. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med 2000;342:1007–1014.

449. Wheatley K, Ives N, Gray R, Kalra PA, Moss JG, Baigent C, Carr S, Chalmers N, Eadington D, Hamilton G, Lip-kin G, Nicholson A, Scoble J. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med 2009;361:1953–1962.

450. Schwarzwalder U, Hauk M, Zeller T. RADAR—a randomised, multi-centre, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with haemodynamically relevant atherosclerotic renal artery stenosis. Trials 2009;10:60.

451. Bax L, Woittiez AJ, Kouwenberg HJ, Mali WP, Buskens E, Beek FJ, Braam B, Huysmans FT, Schultze Kool LJ, Rut-ten MJ, Doorenbos CJ, Aarts JC, Rabelink TJ, Plouin PF, Raynaud A, van Montfrans GA, Reekers JA, van den Meiracker AH, Pattynama PM, van de Ven PJ, Vroegindeweij D, Kroon AA, de Haan MW, Postma CT, Beutler JJ. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann Intern Med 2009;150:840–848, W150–W151.

452. Balzer KM, Pfeiffer T, Rossbach S, Voiculescu A, Modder U, Godehardt E, Sandmann W. Prospective random-ized trial of operative vs interventional treatment for renal artery ostial occlusive disease (RAOOD). J Vasc Surg 2009;49:667–674; discussion 674–665.

453. Naylor R, Cuffe RL, Rothwell PM, Loftus IM, Bell PR. A systematic review of outcome following synchronous carotid endarterectomy and coronary artery bypass: influence of surgical and patient variables. Eur J Vasc Endovasc Surg 2003;26:230–241.

454. Kolh PH, Comte L, Tchana-Sato V, Honore C, Kerzmann A, Mauer M, Limet R. Concurrent coronary and carotid artery surgery: factors influencing perioperative outcome and long-term results. Eur Heart J 2006;27:49–56.

455. Hill MD, Shrive FM, Kennedy J, Feasby TE, GhaliWA. Simultaneous carotid endarterectomy and coronary artery bypass surgery in Canada. Neurology 2005;64:1435–1437. Page 8 of 9 ESC Guidelines

456. Brown KR, Kresowik TF, Chin MH, Kresowik RA, Grund SL, Hendel ME. Multistate population-based outcomes of combined carotid endarterectomy and coronary artery bypass. J Vasc Surg 2003;37:32–39.

457. Dubinsky RM, Lai SM. Mortality from combined carotid endarterectomy and coronary artery bypass surgery in the US. Neurology 2007;68:195–197.

458. Byrne J, Darling RC 3rd, Roddy SP, Mehta M, Paty PS, Kreienberg PB, Chang BB, Ozsvath KJ, Shah DM. Combined carotid endarterectomy and coronary artery bypass grafting in patients with asymptomatic high-grade stenoses: an analysis of 758 procedures. J Vasc Surg 2006;44:67–72.

459. Kougias P, Kappa JR, Sewell DH, Feit RA, Michalik RE, Imam M, Greenfield TD. Simultaneous carotid endarterectomy and coronary artery bypass grafting: results in specific patient groups. Ann Vasc Surg 2007;21:408–414.

460. Char D, Cuadra S, Ricotta J, Bilfinger T, Giron F, McLarty A, Krukenkamp I, Saltman A, Seifert F. Combined coronary artery bypass and carotid endarterectomy: long-term results. Cardiovasc Surg 2002;10:111–115.

461. Cywinski JB, Koch CG, Krajewski LP, Smedira N, Li L, Starr NJ. Increased risk associated with combined carotid endarterectomy and coronary artery bypass graft surgery: a propensity-matched comparison with isolated coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2006;20:796–802.

462. Ricotta JJ,Wall LP, Blackstone E. The influence of concurrent carotid endarterectomy on coronary bypass: a case-controlled study. J Vasc Surg 2005;41:397–401;discussion 401–392.

463. Timaran CH, Rosero EB, Smith ST, Valentine RJ, Modrall JG, Clagett GP. Trends and outcomes of concurrent carotid revascularization and coronary bypass. J Vasc Surg 2008;48:355–361. e351.

464. Ziada KM, Yadav JS, Mukherjee D, Lauer MS, Bhatt DL, Kapadia S, Roffi M, Vora N, Tiong I, Bajzer C. Comparison of results of carotid stenting followed by open heart surgery versus combined carotid endarterectomy and open heart surgery (coronary bypass with or without another procedure). Am J Cardiol 2005;96:519–523.

465. Kovacic JC, Roy PR, Baron DW, Muller DW. Staged carotid artery stenting and coronary artery bypass graft surgery: initial results from a single center. Catheter Cardiovasc Interv 2006;67:142–148.

466. Randall MS, McKevitt FM, Cleveland TJ, Gaines PA, Venables GS. Is there any benefit from staged carotid and coronary revascularization using carotid stents? A single-center experience highlights the need for a random-ized controlled trial. Stroke 2006;37:435–439.

467. Mendiz O, Fava C, Valdivieso L, Dulbecco E, Raffaelli H, Lev G, Favaloro R. Synchronous carotid stenting and cardiac surgery: an initial single-center experience. Catheter Cardiovasc Interv 2006;68:424–428.

468. Versaci F, Reimers B, Del Giudice C, Schofer J, Giacomin A, Sacca S, Gandini R, Albiero R, Pellegrino A, Bertol-do F, Simonetti G, Chiariello L. Simultaneous hybrid revascularization by carotid stenting and coronary artery bypass grafting: the SHARP study. JACC Cardiovasc Interv 2009;2:393–401.

469. Van der Heyden J, Suttorp MJ, Bal ET, Ernst JM, Ackerstaff RG, Schaap J, Kelder JC, Schepens M, Plokker HW. Staged carotid angioplasty and stenting followed by cardiac surgery in patients with severe asymptomatic carotid artery stenosis: early and long-term results. Circulation 2007;116:2036–2042.


For citation:


., ., ., ., ., ., ., ., ., ., ., ., ., ., ., ., ., ., ., ., . . Rational Pharmacotherapy in Cardiology. 2012;8(4):4-73. (In Russ.) https://doi.org/10.20996/1819-6446-2012-8-4-4-73

Views: 306


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)